Diseases of the myoneural junction and muscle

G6_MYONEU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G70-G73, G71.10#, G71.11, G71.12, G71.13, G71.14, G71.15, G71.18 Cause of death: ICD-10 — G70-G73, G71.10#, G71.11, G71.12, G71.13, G71.14, G71.15, G71.18 2 out of 7 registries used, show all original rules.	5912
4. Check minimum number of events None	5912
5. Include endpoints G6_MYASTHENIA G6_TOXMYONEU G6_CONDEVMYA G6_MYONEUOTHUNS G6_MUSDYST G6_MYOTDIS G6_CONMYOP G6_MITOCMY G6_MUSCOTHUNS G6_DRUGMYOP G6_ALCOMYOP G6_MYOPTOX G6_PERIOPAR G6_INFLAMYOP G6_MYOPOTHUNS G6_MYOMUSCINOTH	6006
6. Filter based on genotype QC (FinnGen only)	5371

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_MYONEU
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_MYASTHENIA\|G6_TOXMYONEU\|G6_CONDEVMYA\|G6_MYONEUOTHUNS\|G6_MUSDYST\|G6_MYOTDIS\|G6_CONMYOP\|G6_MITOCMY\|G6_MUSCOTHUNS\|G6_DRUGMYOP\|G6_ALCOMYOP\|G6_MYOPTOX\|G6_PERIOPAR\|G6_INFLAMYOP\|G6_MYOPOTHUNS\|G6_MYOMUSCINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G7
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G7
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases of the myoneural junction and muscle based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42435	19202	22973
Only index persons	37440	17431	20009
Unadjusted period prevalence (%)
Whole population	0.60	0.55	0.64
Only index persons	0.71	0.64	0.76
Median age at first event (years)
Whole population	64.79	68.78	61.48
Only index persons	65.24	69.09	61.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5371	2484	2887
Unadjusted period prevalence (%)	1.12	0.88	1.32
Median age at first event (years)	63.14	61.47	64.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5545: Matched controls
55450

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1AD

NOMESCO Finland

CT of head and brain

2.9

322.0

2503

12196

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

42.7

317.3

190

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.7

307.7

2072

7632

G72.9

ICD-10 Finland

Myopathy, unspecified

1722.5

307.7

1213

G72.8

ICD-10 Finland

Other specified myopathies

5325.9

307.7

2849

N07AA02

ATC

pyridostigmine; systemic

232.4

307.7

564

NXL00

NOMESCO Finland

Biopsy of muscle

47.8

307.7

225

108

Kela drug reimbursment

Myasthenia gravis

+∞

307.7

466

G70.0

ICD-10 Finland

Myasthenia gravis

+∞

307.7

598

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

41.1

302.7

183

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.1

289.2

894

2458

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.6

285.1

759

1862

L28

ICPC

Limited function/disability (L)

2.9

265.2

1750

7664

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

49.4

233.1

135

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.7

231.0

572

1317

G71.08

ICD-10 Finland

Other muscular dystrophy

2194.0

229.6

221

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.4

224.4

465

919

N99

ICPC

Neurological disease other

10.0

218.7

253

263

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

+∞

216.1

206

A28

ICPC

Limited function/disability NOS

2.6

207.5

1602

7461

L04AX01

ATC

azathioprine; systemic

4.9

195.8

459

1007

M60.8

ICD-10 Finland

Other myositis

40.2

194.2

118

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

184.7

2309

13207

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

183.3

1042

4124

M60.9

ICD-10 Finland

Myositis, unspecified

16.6

183.0

154

N05AH04

ATC

quetiapine; oral

2.6

179.3

1295

5786

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.6

173.7

342

643

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

173.2

1401

6594

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

164.5

634

1992

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

+∞

163.3

156

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.9

159.0

499

1365

M33.2

ICD-10 Finland

Polymyositis

35.1

158.8

100

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.8

156.0

294

530

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

151.9

1951

11081

N05AH03

ATC

olanzapine; systemic

3.6

151.7

546

1638

SPAT1216

SPAT

Assessment of functional ability

2.5

151.3

1242

5842

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.9

151.3

280

496

N03AE01

ATC

clonazepam; systemic

3.6

150.7

531

1571

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.4

149.8

600

1927

R53

ICD-10 Finland

Malaise and fatigue

2.2

149.2

1762

9667

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

148.9

568

1769

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

9.5

146.1

175

190

N28

ICPC

Limited function/disability (N)

6.2

143.3

251

421

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.7

141.6

228

351

SPAT1229

SPAT

Assessment of need for aid

3.0

141.3

692

2501

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

139.9

1189

5659

N03AG01

ATC

valproic acid; systemic, rectal

3.5

139.4

511

1549

N05AA02

ATC

levomepromazine; systemic

4.2

138.1

388

977

N07AA03

ATC

distigmine; systemic

22.4

134.9

SPAT1254

SPAT

Administration of medicine

2.4

134.4

1129

5337

G71.18

ICD-10 Finland

Other myotonic disease

329.7

129.0

130

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.0

126.8

230

399

G71.11

ICD-10 Finland

Dystrophia myotonica [Steinert]

+∞

126.5

121

N05BA01

ATC

diazepam; systemic, rectal

2.5

125.4

947

4254

F10.24

ICD-10 Finland

Alcohol depence active use

6.9

124.2

194

289

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

416.7

123.2

123

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

119.4

1098

5370

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

119.3

832

3595

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

118.8

888

3963

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

+∞

118.1

113

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

117.8

3020

21340

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.4

116.4

233

443

G71.8

ICD-10 Finland

Other primary disorders of muscles

+∞

116.0

111

G71.12

ICD-10 Finland

Myotonia congenita

+∞

115.0

110

N05AF03

ATC

chlorprothixene; systemic

5.0

114.3

252

522

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.9

113.8

207

360

C03CA01

ATC

furosemide; systemic

1.9

113.7

2163

13818

R1250

NOMESCO Finland

Evaluation of functional capability

4.6

113.0

275

618

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.8

112.0

157

207

G72.0

ICD-10 Finland

Drug-induced myopathy

1100.3

110.9

108

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

110.8

696

2852

N06AX11

ATC

mirtazapine; oral

1.9

110.4

2084

13247

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

110.4

1162

5988

P15

ICPC

Chronic alcohol abuse

4.4

110.3

287

680

H53.2

ICD-10 Finland

Diplopia

4.0

109.7

329

867

N05AX08

ATC

risperidone; systemic

2.6

109.1

693

2854

N03AX16

ATC

[U] pregabalin

2.0

108.7

1483

8424

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.7

108.3

205

370

SPAT1172

SPAT

Guidance concerning hydration

4.6

108.3

264

594

Z31.5

ICD-10 Finland

Genetic counselling

3.5

107.9

390

1167

N03AX09

ATC

lamotrigine; oral

3.7

107.8

358

1013

N07BB01

ATC

disulfiram; oral

3.7

107.7

356

1004

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

107.5

990

4825

SPAT1234

SPAT

Support of social functional capacity

3.1

107.2

482

1649

N05CD07

ATC

temazepam; oral

2.4

106.8

877

4069

N29

ICPC

Neurological sympt/complt other

5.2

104.5

222

445

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

104.3

426

1376

R03CA02

ATC

ephedrine; oral

26.6

103.3

N06AB04

ATC

citalopram; systemic

2.0

99.9

1289

7143

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.8

99.9

185

327

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

98.9

344

1003

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

97.8

2088

13672

E86

ICD-10 Finland

Volume depletion

4.1

97.1

274

690

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.2

96.1

409

1353

N05BA04

ATC

oxazepam; oral

1.9

95.3

1614

9801

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

116.6

95.3

103

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.7

94.1

120

141

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

94.1

488

1805

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

10.6

92.9

102

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

91.7

961

4908

H02.4

ICD-10 Finland

Ptosis of eyelid

3.9

91.1

277

736

M62.9

ICD-10 Finland

Disorder of muscle, unspecified

13.8

89.5

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.4

89.2

227

528

N03AX12

ATC

[U] gabapentin; oral

2.1

89.0

1033

5481

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

87.8

559

2295

N06AX21

ATC

duloxetine; oral

2.3

87.4

764

3620

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.6

87.1

214

484

A04

ICPC

Weakness/tiredness general

2.0

86.3

1063

5757

N17.8

ICD-10 Finland

Other acute renal failure

5.7

86.0

162

291

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.3

85.7

340

1077

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

85.5

693

3177

A46

ICD-10 Finland

Erysipelas

2.0

82.9

1029

5582

M62.8

ICD-10 Finland

Other specified disorders of muscle

14.4

81.8

S01.0

ICD-10 Finland

Open wound of scalp

2.4

81.7

612

2708

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

81.2

605

2670

WX892

NOMESCO Finland

Monitored bed care

2.5

80.5

562

2407

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.7

80.3

189

413

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

79.8

1180

6791

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

79.7

677

3163

N06AX16

ATC

venlafaxine; oral

2.2

79.6

819

4136

N05AH02

ATC

clozapine; systemic

5.4

79.2

159

303

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

78.5

393

1423

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

78.5

1679

10841

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

78.2

294

900

Z2446

NOMESCO Finland

Social worker

2.7

78.1

461

1820

R13

ICD-10 Finland

Dysphagia

2.5

77.3

529

2243

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

14.2

76.7

F05.9

ICD-10 Finland

Delirium, unspecified

3.9

74.9

227

601

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.9

74.9

116

171

T68

ICD-10 Finland

Hypothermia

10.0

74.6

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.4

74.4

284

877

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.3

73.5

195

468

S97

ICPC

Chronic ulcer skin

2.5

73.5

498

2100

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

73.5

848

4462

W19

ICD-10 Finland

Unspecified fall

2.2

73.4

688

3341

TAB00

NOMESCO Finland

Lumbar puncture

3.1

72.9

320

1075

N04AA02

ATC

biperiden; systemic

4.8

72.8

166

353

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.3

72.7

124

202

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

72.7

401

1528

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

72.3

1741

11572

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.5

71.8

255

752

N05CF01

ATC

zopiclone; oral

1.7

71.6

1898

12945

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

70.1

868

4678

G72.4

ICD-10 Finland

Inflammatory myopathy, not elsewhere classified

+∞

69.9

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

69.7

523

2309

S06.0

ICD-10 Finland

Concussion

2.1

69.1

703

3522

N06AA09

ATC

amitriptyline; systemic

2.2

68.6

619

2956

A06AD11

ATC

lactulose; oral

1.9

67.8

998

5702

ZXD05

NOMESCO Finland

Urgent procedure

1.7

67.6

1704

11427

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.7

67.3

216

595

Z3226

NOMESCO Finland

Physiotherapist

1.9

66.6

1092

6457

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

65.1

538

2475

E87.6

ICD-10 Finland

Hypokalaemia

3.1

64.8

284

953

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.6

63.4

154

345

R60.0

ICD-10 Finland

Localized oedema

2.0

62.7

833

4587

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

62.7

850

4713

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

62.5

303

1076

N05BA02

ATC

chlordiazepoxide; systemic

3.7

62.1

201

557

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.3

61.9

104

167

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

61.8

743

3950

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

61.8

589

2870

L99

ICPC

Musculoskeletal disease other

3.8

61.7

194

527

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

+∞

61.6

N18

ICPC

Paralysis/weakness

3.8

61.3

190

511

N05AX12

ATC

aripiprazole; systemic

3.2

60.6

244

778

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

24.1

60.2

H02AB06

ATC

prednisolone; systemic

1.6

60.1

2637

20150

SPAT1301

SPAT

No procedures

1.6

60.0

1770

12288

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

59.9

517

2418

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

59.8

983

5797

TNX05

NOMESCO Finland

Simple incision of soft tissue, unspecified region

17.0

59.1

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.4

59.1

117

220

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.6

58.4

363

1465

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

58.4

372

1520

SPAT1167

SPAT

Insertion of urinary catheter

3.0

58.3

266

913

N06AB03

ATC

fluoxetine; oral

2.0

58.1

682

3591

N02AA05

ATC

oxycodone; systemic

1.8

57.9

1173

7353

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

57.8

955

5635

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

57.6

538

2598

TK800

NOMESCO Finland

Hemodialysis

3.7

57.4

185

511

3580A

ICD-9 Finland

Myoneural disorders, Myasthenia gravis

+∞

57.4

R5110, ,

SPAT

2.1

56.8

580

2899

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.8

56.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

55.7

504

2402

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.0

55.6

160

408

L19

ICPC

Muscle symptom/complaint NOS

3.2

55.4

221

701

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

54.4

413

1827

N03AF01

ATC

carbamazepine; oral, rectal

2.5

53.7

345

1414

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

53.1

348

1440

J96.1

ICD-10 Finland

Chronic respiratory failure

3.5

52.9

189

559

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.3

52.6

G70

ICD-10 Finland

Myasthenia gravis and other myoneural disorders

522.9

52.6

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.6

52.4

328

1328

A02BC02

ATC

pantoprazole; systemic

1.6

51.8

3721

31314

R4130

NOMESCO Finland

Speech therapy

3.2

51.8

213

688

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.3

51.4

103

196

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.9

51.3

161

N05BE01

ATC

buspirone; oral

3.2

51.0

204

648

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.2

50.7

104

202

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

9.9

50.7

N06AA12

ATC

doxepin; systemic

2.5

50.6

332

1374

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

50.5

619

3301

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.5

50.5

174

503

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

7.0

50.3

112

N05AN01

ATC

lithium; oral

3.7

50.0

163

454

N03AX14

ATC

levetiracetam; systemic

3.1

49.9

217

724

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

49.7

274

1041

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.4

49.5

178

529

N05AD01

ATC

haloperidol; systemic

2.9

49.3

234

821

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.8

49.2

262

977

73300

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Myasthenia gravis

+∞

49.0

N02BE01

ATC

paracetamol; systemic, rectal

1.8

48.7

4837

43715

N02AX02

ATC

tramadol; systemic, rectal

1.5

48.6

2350

18054

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

13.2

48.5

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

48.0

457

2219

N05AA01

ATC

chlorpromazine; systemic, rectal

4.7

47.8

111

240

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

47.6

425

2011

R4110

NOMESCO Finland

Physiotherapy

1.6

47.5

1538

10796

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.0

47.4

221

767

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.5

47.3

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

47.2

456

2225

N05AB03

ATC

perphenazine; systemic, rectal

2.9

47.2

226

796

R50.9

ICD-10 Finland

Fever, unspecified

1.8

47.0

884

5390

SPAT1263

SPAT

Sampling

1.5

46.9

2183

16598

M62.5

ICD-10 Finland

Muscle wasting and atrophy, not elsewhere classified

14.0

46.8

WX730

NOMESCO Finland

Conventional respirator

4.1

46.6

130

324

R4120

NOMESCO Finland

Occupational therapy

2.2

46.6

409

1921

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

46.2

431

2074

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

45.6

240

890

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

45.2

1242

8366

Z72.1

ICD-10 Finland

Alcohol use

4.6

45.2

108

239

H02AB07

ATC

prednisone; oral

1.8

45.2

767

4535

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

5.9

45.1

139

N06AB10

ATC

escitalopram; oral

1.7

45.1

996

6345

N06AB06

ATC

sertraline; oral

1.9

44.9

586

3186

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

84.2

44.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

44.5

754

4453

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

44.2

556

2986

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

44.1

207

721

N05BA12

ATC

alprazolam; oral

2.0

44.1

558

3002

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

44.1

163

493

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

44.0

1235

8356

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

43.5

681

3925

C07AB07

ATC

bisoprolol; oral

1.5

43.4

2755

22193

SPAT1240

SPAT

Therapeutic discussion

2.0

43.4

501

2611

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.4

43.0

109

253

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

7.1

42.3

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

42.2

274

1127

P16

ICPC

Acute alcohol abuse

4.0

42.2

121

308

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.1

42.1

116

287

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.0

41.9

194

671

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

41.8

1010

6571

G72

ICD-10 Finland

Other myopathies

147.8

41.8

R42

ICD-10 Finland

Dizziness and giddiness

1.6

41.7

1303

9024

G71.0

ICD-10 Finland

Muscular dystrophy

+∞

41.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

41.7

277

1152

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

41.6

421

2089

N05AC02

ATC

thioridazine; oral

3.7

41.6

135

375

Z3231

NOMESCO Finland

Registered nurse

1.5

41.4

1486

10616

R06.0

ICD-10 Finland

Dyspnoea

1.5

41.4

1529

10993

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.6

41.4

136

381

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.7

41.3

204

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

41.0

965

6234

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.5

41.0

100

225

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

41.0

548

3001

J01FF01

ATC

clindamycin; systemic

1.6

40.8

1416

10035

G72.1

ICD-10 Finland

Alcoholic myopathy

+∞

40.7

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.4

40.6

102

235

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

40.4

400

1968

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.8

40.3

196

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.7

40.3

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.1

40.1

169

554

M03BX01

ATC

baclofen; systemic

3.4

39.9

143

424

E0000UV, ,

ATC

1.5

39.4

2141

16623

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.0

39.4

N06AX03

ATC

mianserin; oral

2.3

39.3

297

1309

P72

ICPC

Schizophrenia

3.6

39.2

131

371

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.1

39.2

107

263

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

64.8

39.1

E87.2

ICD-10 Finland

Acidosis

6.2

39.1

110

L04AA06

ATC

mycophenolic acid; systemic

3.4

39.0

140

416

P99

ICPC

Psychological disorders other

3.0

38.9

179

617

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.5

38.8

241

971

P29

ICPC

Psychological sympt/compl other

2.1

38.7

367

1776

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.9

38.6

115

301

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

38.6

257

1070

G70.8

ICD-10 Finland

Other specified myoneural disorders

+∞

38.6

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.6

38.2

197

C07AA05

ATC

propranolol; systemic

1.6

38.0

976

6432

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

38.0

926

6024

N03AF02

ATC

oxcarbazepine; oral

2.7

38.0

209

793

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

37.9

691

4158

3599X

ICD-9 Finland

Muscular dystrophies and other myopathies, Myopathy, unspecified

+∞

37.5

G71.28

ICD-10 Finland

Other congenital myopathy

+∞

37.5

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

5.1

37.4

154

Z72.2

ICD-10 Finland

Drug use

7.2

37.2

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

37.2

205

778

SPAT1125

SPAT

Stoma care and guidance

3.4

36.7

135

407

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.4

36.6

212

WX882

NOMESCO Finland

High dependency care

2.7

36.6

196

733

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.2

36.5

148

474

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

36.5

191

706

R55

ICD-10 Finland

Syncope and collapse

1.8

36.4

667

4018

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

36.3

381

1914

N05AF05

ATC

zuclopenthixol; systemic

5.1

35.7

149

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.1

35.7

149

A29

ICPC

General symptom/complaint other

1.7

35.7

779

4920

A01

ICPC

Pain general/multiple sites

1.8

35.7

580

3372

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.5

35.6

192

V03AA01, ,

ATC

3.6

35.6

117

328

R33

ICD-10 Finland

Retention of urine

1.9

35.6

524

2955

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

35.4

549

3146

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.1

35.3

150

494

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

35.1

442

2369

M79.1

ICD-10 Finland

Myalgia

1.7

35.0

749

4703

S18

ICPC

Laceration/cut

1.4

34.8

2511

20397

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

34.7

498

2784

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.1

34.6

230

F34.1

ICD-10 Finland

Dysthymia

2.6

34.5

203

797

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.7

34.4

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

34.2

736

4627

J01DB01

ATC

cefalexin; oral

1.5

34.2

4341

39041

N30.0

ICD-10 Finland

Acute cystitis

1.6

34.2

878

5774

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

34.1

501

2823

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.5

34.0

183

Y94.0

ICD-10 Finland

Accident at home

3.1

33.8

142

465

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

33.6

280

1285

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.5

33.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

33.4

440

2392

WW400

NOMESCO Finland

Plasmaferesis

12.9

33.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

33.1

523

3013

F61.0

ICD-10 Finland

Mixed personality disorders

3.9

33.1

247

M48.0

ICD-10 Finland

Spinal stenosis

1.7

32.9

708

4447

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

32.9

882

5856

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

8.1

32.8

K08.3

ICD-10 Finland

Retained dental root

1.9

32.8

458

2539

N02BF02

ATC

pregabalin; oral

2.0

32.7

379

1972

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

32.5

182

697

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

32.4

1309

9509

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

32.3

608

3682

G71.06

ICD-10 Finland

Muscular dystrophy severe [Duchenne]

+∞

32.3

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

32.3

M79.6

ICD-10 Finland

Pain in limb

1.4

32.3

2210

17709

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

32.2

287

1354

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

9.8

32.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

32.1

1519

11381

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.4

31.9

113

333

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

31.9

259

1177

A08

ICPC

Swelling

2.0

31.7

352

1804

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

11.9

31.6

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

31.5

508

2942

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

5.8

31.4

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

7.6

31.4

5872

FHL

Thymic exploration or thymectomy

+∞

31.3

N05CF02

ATC

zolpidem; oral

1.6

31.3

847

5632

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

9.8

31.2

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

6.5

31.0

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.4

31.0

176

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

31.0

1031

7181

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.3

30.9

AA1XD

NOMESCO Finland

Other special CT of head and brain

7.1

30.9

U04

ICPC

Incontinence urine

2.0

30.8

364

1908

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

30.8

526

3099

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

10.4

30.7

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

30.6

674

4255

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.9

30.4

135

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

30.4

1300

9534

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

9.1

30.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.7

30.3

167

634

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

30.2

179

705

C03DA01

ATC

spironolactone; oral

1.6

30.2

716

4607

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

30.1

635

3963

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

4.8

30.1

144

N02BF01

ATC

gabapentin; oral

1.7

29.9

543

3254

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

29.9

173

674

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

29.8

298

1469

A12BA01

ATC

potassium chloride; oral

2.1

29.7

277

1330

M05BA04

ATC

alendronic acid; oral

1.8

29.7

498

2917

R52.2

ICD-10 Finland

Other chronic pain

2.3

29.7

222

974

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.3

29.6

111

339

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

29.5

469

2702

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

29.5

318

1613

SPAT1265

SPAT

Breathalyser

4.5

29.4

159

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

29.3

529

3163

L76

ICPC

Fracture: other

2.4

29.3

207

885

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.2

29.2

244

1121

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

29.2

708

4577

A02BC01

ATC

omeprazole; systemic

1.4

29.2

1403

10506

H02AB09

ATC

hydrocortisone; systemic

2.8

29.1

152

562

SPAT1262

SPAT

Handing over of treatment supplies

1.5

29.1

931

6422

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

29.0

265

1262

D21

ICPC

Swallowing problem

3.2

28.9

117

375

X58

ICD-10 Finland

Exposure to other specified factors

1.6

28.9

749

4922

N06AX26

ATC

vortioxetine; oral

1.9

28.8

368

1980

WX872

NOMESCO Finland

Intensive care

2.0

28.7

307

1552

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

28.7

1796

14093

GEC23

NOMESCO Finland

Transsternal thymectomy

44.0

28.6

SPAT1227

SPAT

Substance abuse rehabilitation

5.9

28.6

P01BA02

ATC

hydroxychloroquine; oral

1.9

28.6

412

2303

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

28.6

2022

16199

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.8

28.4

233

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

28.2

272

1324

G71.25

ICD-10 Finland

Congenital muscular dystrophy NOS

+∞

28.1

G71.02

ICD-10 Finland

Muscular dystrophy facioscapulohumeral

+∞

28.1

SPAT1252

SPAT

Overall medication plan or its review

1.9

28.0

389

2150

R27.0

ICD-10 Finland

Ataxia, unspecified

5.9

27.7

ZZA00

NOMESCO Finland

Split skin graft

2.5

27.6

182

754

J01MA12

ATC

levofloxacin; systemic

1.5

27.6

984

6936

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

27.5

419

2384

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.5

27.4

281

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

27.4

373

2048

ZY000

NOMESCO Finland

Hospital inpatient

3.8

27.4

225

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

27.4

259

1251

R51.80

ICD-10 Finland

Headache

1.6

27.3

732

4846

OAB43, ,

SPAT

0.6

27.2

529

8308

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.5

27.1

176

724

F20.0

ICD-10 Finland

Paranoid schizophrenia

5.2

27.1

106

F31

ICD-10 Finland

Bipolar affective disorder

4.1

27.1

182

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

27.1

1385

10468

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

27.0

234

1092

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

26.9

117

391

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

26.8

128

451

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

26.7

157

616

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

26.7

179

748

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

26.6

356

1944

P03

ICPC

Feeling depressed

1.8

26.6

426

2460

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

26.5

1335

10054

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.9

26.5

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.5

26.3

140

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.4

26.3

186

796

SPAT1211

SPAT

Application of soft bandage

1.7

26.2

462

2741

Z08

ICPC

Social welfare problem

3.5

26.1

261

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

9.7

25.9

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

5.5

25.8

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.5

25.8

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.6

25.7

149

581

XA402

NOMESCO Finland

ENMG

2.6

25.7

145

558

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

25.6

225

1056

SPAT1260

SPAT

Consultation of another employee

1.5

25.5

866

6032

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

6.5

25.5

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

25.5

588

3748

N05AL01

ATC

sulpiride; systemic

3.3

25.4

295

P18

ICPC

Medication abuse

4.6

25.4

128

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

25.2

393

2249

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.4

25.2

262

N03AB02

ATC

phenytoin; systemic

3.5

25.2

243

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.1

25.1

106

349

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.6

25.0

142

548

G73.0*E05.9

ICD-10 Finland

Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]

+∞

25.0

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

+∞

25.0

X31

ICD-10 Finland

Exposure to excessive natural cold

6.9

25.0

UJF32

NOMESCO Finland

Coloscopy

1.4

25.0

1345

10235

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

24.8

373

2111

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

24.8

156

633

G71.1

ICD-10 Finland

Myotonic disorders

70.2

24.8

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

4.9

24.8

111

JN4AD

NOMESCO Finland

Body CT examination

1.6

24.8

624

4063

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.6

24.8

142

551

P20

ICPC

Memory disturbance

1.5

24.7

822

5700

SPAT1360

SPAT

Extensive global examination

1.8

24.7

364

2049

SPAT1053

SPAT

Memory test

1.5

24.6

796

5485

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

6.8

24.6

RS142, ,

NOMESCO Finland

8.7

24.5

N06AA10

ATC

nortriptyline; systemic

2.8

24.5

119

424

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

24.3

520

3251

XF404

NOMESCO Finland

Ambulatory ECG

1.7

24.3

468

2846

G12.2

ICD-10 Finland

Motor neuron disease

4.6

24.2

125

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

24.2

315

1704

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

24.1

193

872

N06AX05

ATC

trazodone; oral

2.6

24.1

136

524

N05CD02

ATC

nitrazepam; oral

2.9

24.0

110

379

G72.3

ICD-10 Finland

Periodic paralysis

+∞

24.0

G70.20

ICD-10 Finland

Congenital and developmental myasthenia

+∞

24.0

S22.3

ICD-10 Finland

Fracture of rib

1.8

24.0

410

2412

R4110, ,

SPAT

1.6

23.9

681

4561

TK810

NOMESCO Finland

Hemofiltration

4.9

23.8

107

H03AA01

ATC

levothyroxine sodium; systemic

1.4

23.8

1078

7939

Z50.1

ICD-10 Finland

Other physical therapy

1.9

23.8

287

1513

6BA02, ,

NOMESCO Finland

7.7

23.8

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

23.8

572

3682

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

23.7

102

339

RS221, ,

NOMESCO Finland

3.2

23.7

288

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

23.7

2039

16711

M54.5

ICD-10 Finland

Low back pain

1.4

23.6

1762

14124

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

23.6

285

1503

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.5

23.6

149

606

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

6.6

23.4

P19

ICPC

Drug abuse

4.4

23.3

133

R11

ICD-10 Finland

Nausea and vomiting

1.7

23.3

446

2706

OAA80, ,

SPAT

0.3

23.2

2478

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.3

23.2

142

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

23.2

664

4453

SPAT1139

SPAT

Nutrition survey

2.2

23.1

195

900

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

23.1

139

552

N03AX18

ATC

lacosamide; systemic

4.4

23.1

134

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

8.4

23.1

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

23.1

944

6815

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.3

22.9

259

R25.2

ICD-10 Finland

Cramp and spasm

2.5

22.9

145

591

G56.3

ICD-10 Finland

Lesion of radial nerve

4.2

22.8

148

IGV01

NOMESCO Finland

Psychiatric network contact

3.8

22.8

179

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

22.8

466

2879

N06AA06

ATC

trimipramine; systemic

2.6

22.7

135

533

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

22.7

1313

10089

L29

ICPC

Musculoskeletal sympt/complt other

1.7

22.7

463

2858

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.5

22.7

231

Z2221

NOMESCO Finland

Medical doctor

1.4

22.5

1298

9968

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.1

22.4

150

G12.8

ICD-10 Finland

Other spinal muscular atrophies and related syndromes

32.4

22.4

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.1

22.4

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

22.3

195

914

R4120, ,

SPAT

3.1

22.3

299

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

5.8

22.2

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.3

22.2

XG466

NOMESCO Finland

Sleep oxymetry

2.3

22.2

174

779

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

22.2

1728

13915

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

18.0

22.1

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.1

22.1

306

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

21.9

109

393

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

21.9

613

4085

R5130, ,

SPAT

5.7

21.9

ZY010

NOMESCO Finland

Hospital outpatient

2.0

21.9

242

1238

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

21.9

844

6019

G73.1*C80.99

ICD-10 Finland

Eaton-Lambert syndrome

+∞

21.9

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

21.8

246

1267

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.2

21.7

F03

ICD-10 Finland

Unspecified dementia

1.9

21.7

268

1425

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

21.7

902

6528

G70.28

ICD-10 Finland

Other congenital and developmental myasthenia

80.4

21.7

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

21.6

439

2706

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

21.6

386

2298

G04BD12

ATC

mirabegron; oral

1.5

21.6

642

4338

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

21.5

530

3429

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

21.5

561

3679

Z2445

NOMESCO Finland

Psychologist

2.2

21.5

185

862

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

21.3

629

4240

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.0

21.3

312

N87

ICPC

Parkinsonism

2.8

21.1

109

401

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

21.0

189

896

B01AB05

ATC

enoxaparin; parenteral

1.4

20.9

1562

12473

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

20.9

288

1587

A41.8

ICD-10 Finland

Other specified sepsis

2.6

20.9

125

496

G72.2

ICD-10 Finland

Myopathy due to other toxic agents

+∞

20.8

3591A

ICD-9 Finland

Muscular dystrophies and other myopathies, Hereditary progressive muscular dystrophy

+∞

20.8

SPAT1153

SPAT

Removal of sutures

1.4

20.8

1551

12378

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

20.8

2116

17668

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

6.0

20.7

R40.2

ICD-10 Finland

Coma, unspecified

3.6

20.7

187

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

20.6

1832

15004

SPAT1310

SPAT

Counselling related to known health issue

1.4

20.6

1494

11872

N05AB01

ATC

dixyrazine; systemic

3.3

20.6

231

UKC02

NOMESCO Finland

Cystoscopy

1.4

20.6

874

6345

ZXE00

NOMESCO Finland

One hour or less

1.3

20.5

1843

15113

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

20.5

618

4184

N05AE04

ATC

ziprasidone; systemic

5.8

20.5

S70.0

ICD-10 Finland

Contusion of hip

2.0

20.5

229

1176

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.7

20.5

174

R4190

NOMESCO Finland

Nutritional therapy

2.1

20.4

203

1000

2AB04, ,

NOMESCO Finland

7.8

20.4

Z03

ICPC

Housing/neighbourhood problem

4.2

20.2

131

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

20.2

680

4712

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

20.2

309

1758

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.2

20.2

127

G60.0

ICD-10 Finland

Hereditary motor and sensory neuropathy

8.4

20.1

R52.9

ICD-10 Finland

Pain, unspecified

1.6

20.1

504

3272

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

20.1

196

959

H50.2

ICD-10 Finland

Vertical strabismus

4.1

20.0

132

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

20.0

503

3267

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

20.0

1782

14586

P28

ICPC

Limited function/disability (P)

3.9

19.9

150

L17

ICPC

Foot/toe symptom/complaint

1.3

19.9

1505

12021

J01DA01

ATC

[U] cefalexin

1.3

19.9

3013

26492

N06AX12

ATC

bupropion; oral

1.8

19.8

288

1613

G70.1

ICD-10 Finland

Toxic myoneural disorders

+∞

19.8

G73.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic amyotrophy

+∞

19.8

T51.0

ICD-10 Finland

Toxic effect: Ethanol

5.5

19.7

M79.7

ICD-10 Finland

Fibromyalgia

2.3

19.7

154

689

RD210, ,

NOMESCO Finland

2.8

19.7

100

365

A99

ICPC

Disease/condition unspecnature/site

1.6

19.7

534

3532

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

19.5

281

1569

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.2

19.5

126

N03AX11

ATC

topiramate; oral

2.6

19.5

109

418

M33.1

ICD-10 Finland

Other dermatomyositis

17.7

19.5

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

24.6

19.5

P76

ICPC

Depressive disorder

1.8

19.5

280

1563

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

7.4

19.5

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.0

19.4

281

F22.0

ICD-10 Finland

Delusional disorder

3.0

19.4

297

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

19.3

382

2337

E87.5

ICD-10 Finland

Hyperkalaemia

2.5

19.2

124

510

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

19.2

1245

9706

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.4

19.1

107

C09AA05

ATC

ramipril; oral

1.4

19.1

1321

10398

H26.3

ICD-10 Finland

Drug-induced cataract

4.5

19.1

103

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

7.5

19.1

H25.8

ICD-10 Finland

Other senile cataract

1.5

19.0

610

4182

A02BC05

ATC

esomeprazole; systemic

1.3

19.0

1949

16240

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.1

18.9

264

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

18.8

250

1362

L04AX03

ATC

methotrexate; systemic

1.6

18.7

450

2891

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

18.7

344

2063

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.8

18.7

325

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

18.7

106

410

G93.4

ICD-10 Finland

Encephalopathy, unspecified

7.0

18.6

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

7.3

18.6

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

18.6

324

1914

SPAT1251

SPAT

Organisation of medication

2.0

18.5

194

974

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.0

18.5

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.7

18.5

355

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

18.5

214

1114

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

18.4

167

795

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

18.4

399

2500

J01MA02

ATC

ciprofloxacin; systemic

1.3

18.4

1959

16387

RS222, ,

NOMESCO Finland

3.1

18.3

243

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

18.3

242

1316

J01EA01

ATC

trimethoprim; systemic

1.4

18.3

1187

9244

EBA00

NOMESCO Finland

Extraction of tooth

1.3

18.3

1712

14067

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.6

18.3

169

NA2AD

NOMESCO Finland

Thoracic spine CT examination

3.9

18.3

137

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

18.2

149

680

P01

ICPC

Feeling anxious/nervous/tense

1.6

18.2

461

2998

Z50.5

ICD-10 Finland

Speech therapy

3.0

18.2

265

OAA67, ,

SPAT

0.6

18.2

258

4434

H02AB04

ATC

methylprednisolone; systemic

1.5

18.1

675

4770

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

18.1

148

676

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

18.1

158

741

C08CA01

ATC

amlodipine; oral

1.3

18.1

2024

17029

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.3

18.1

130

562

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

18.1

166

794

F20

ICD-10 Finland

Schizophrenia

4.2

18.1

112

G47.3

ICD-10 Finland

Sleep apnoea

1.4

18.1

1101

8489

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

18.0

350

2130

R1260

NOMESCO Finland

Evaluation of communicative skills

2.7

18.0

377

N05BA09

ATC

clobazam; oral

4.6

17.9

K07

ICPC

Swollen ankles/oedema

1.8

17.9

270

1530

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

17.8

284

L75

ICPC

Fracture: femur

2.8

17.8

328

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

16.6

17.8

N06AG02

ATC

moclobemide; oral

2.0

17.8

207

1080

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.7

17.7

GEC26

NOMESCO Finland

Mediastinoscopic thymectomy

+∞

17.7

G35

ICD-10 Finland

Multiple sclerosis

3.1

17.7

248

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

17.7

301

1767

S01XA18

ATC

ciclosporin; ophthalmic

4.0

17.7

127

G24.9

ICD-10 Finland

Dystonia, unspecified

6.2

17.6

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

17.6

248

1376

J96.0

ICD-10 Finland

Acute respiratory failure

2.9

17.6

297

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

17.6

2112

17915

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

6.3

17.5

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.9

17.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

17.4

3480

31445

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.4

17.2

121

519

Y96.9

ICD-10 Finland

Unspecified type of accident

2.5

17.1

108

440

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

17.1

270

1551

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

17.1

1304

10390

X78

ICD-10 Finland

Intentional self-harm by sharp object

4.9

17.1

W06

ICD-10 Finland

Fall involving bed

3.3

17.0

187

G40

ICD-10 Finland

Epilepsy

3.5

17.0

163

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.5

17.0

104

418

Z00.0

ICD-10 Finland

General medical examination

1.4

17.0

924

6987

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

17.0

1724

14292

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

7.2

16.9

R02

ICPC

Shortness of breath/dyspnoea

1.5

16.9

675

4831

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

16.9

303

1806

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

16.8

526

3585

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.6

16.8

155

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

16.7

129

575

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

16.7

293

1734

G73.7*M34.8

ICD-10 Finland

Myopathy in scleroderma

63.5

16.7

A02BC03

ATC

lansoprazole; oral

1.3

16.7

1363

10961

E000001, ,

ATC

1.4

16.7

885

6662

G70.21

ICD-10 Finland

Limb girdle myasthenia

+∞

16.7

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

16.6

317

1920

5CM18, ,

NOMESCO Finland

5.4

16.6

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

6.5

16.6

SPAT1104

SPAT

Monitoring of emergency patient

1.7

16.6

322

1959

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

16.6

445

2932

K85

ICD-10 Finland

Acute pancreatitis

2.6

16.6

358

C01BB02

ATC

mexiletine; systemic

6.7

16.6

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.1

16.6

153

734

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.1

16.6

111

NFM10

NOMESCO Finland

Fasciotomy of thigh

7.3

16.5

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.0

16.5

170

850

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

16.5

177

898

NC2AA

NOMESCO Finland

Forearm X-ray examination

2.7

16.4

314

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

16.4

1184

9351

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

16.4

175

886

R52.1

ICD-10 Finland

Chronic intractable pain

3.4

16.4

177

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

16.3

234

1306

N04BC05

ATC

pramipexole; oral

1.6

16.3

374

2377

ZX120

NOMESCO Finland

Intravenous

1.6

16.2

449

2979

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

16.2

3238

29114

X84

ICD-10 Finland

Intentional self-harm by unspecified means

6.5

16.2

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

16.2

222

1223

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

16.1

271

1585

N06AB05

ATC

paroxetine; oral

1.8

16.1

256

1473

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

16.1

368

2334

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

16.1

103

423

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.3

16.1

126

566

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.9

16.1

118

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

16.0

109

460

RF120, ,

NOMESCO Finland

3.0

16.0

236

G20

ICD-10 Finland

Parkinson disease

2.0

16.0

182

942

29999

ICD-8 Finland

Unspecified psychosis

5.1

16.0

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.0

16.0

226

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

15.9

696

5063

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

15.8

101

414

K90

ICPC

Stroke/cerebrovascular accident

2.0

15.8

174

890

WX722

NOMESCO Finland

PEEP

1.8

15.8

231

1297

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

6.6

15.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

15.7

226

1263

33098

ICD-8 Finland

Hereditary neuromuscular disorders, Alii definiti

33.4

15.7

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.4

15.7

109

465

33030

ICD-8 Finland

Hereditary neuromuscular disorders, Progressive muscular dystrophy

+∞

15.6

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.4

15.6

103

429

N05CD08

ATC

midazolam; nasal, systemic

2.2

15.6

126

573

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

15.6

194

1035

D07AC01

ATC

betamethasone; topical

1.3

15.6

1738

14546

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

15.5

510

3510

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.2

15.5

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.1

15.5

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

15.5

227

1276

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

13.7

15.5

RS121, ,

NOMESCO Finland

4.0

15.5

108

G04BD08

ATC

solifenacin; oral

1.6

15.4

334

2091

ZYY01

NOMESCO Finland

Contact between professionals

4.8

15.4

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.5

15.4

378

A10AB05

ATC

insulin aspart; parenteral

1.6

15.3

390

2539

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

15.3

108

464

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

15.3

572

4040

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

6.7

15.3

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

15.3

159

798

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

15.1

276

1653

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

15.1

716

5282

K59.0

ICD-10 Finland

Constipation

1.7

15.1

284

1715

XKC03

NOMESCO Finland

Water cystometry

2.0

15.1

153

761

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

14.9

167

860

Z71.8

ICD-10 Finland

Other specified counselling

1.3

14.9

1547

12814

X57

ICD-10 Finland

Unspecified privation

2.2

14.9

121

552

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

14.9

123

565

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.8

14.8

252

L84

ICD-10 Finland

Corns and callosities

1.9

14.8

178

939

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

14.8

590

4217

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

14.7

163

836

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

14.7

176

927

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.5

14.7

386

R5140, ,

SPAT

2.7

14.7

298

K03.66

ICD-10 Finland

Tooth plaque

1.6

14.7

369

2394

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.3

14.7

112

498

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.8

14.6

204

1130

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

14.6

418

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

5.6

14.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.6

2442

21400

G73.0*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic amyotrophy

+∞

14.6

R03AC02

ATC

salbutamol; inhalant

1.2

14.5

2578

22739

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.2

14.5

116

526

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

3.4

14.5

146

SPAT1281

SPAT

Other administrative function

1.6

14.5

357

2307

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.2

14.5

181

G73.7*M05.3

ICD-10 Finland

Rheumatoid myopathy

150.4

14.5

RS220, ,

NOMESCO Finland

2.8

14.4

256

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.1

14.4

187

NH1AD

NOMESCO Finland

Ankle and foot CT

2.2

14.3

117

535

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

14.3

277

1685

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

14.3

238

1390

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.2

14.3

117

536

K92.1

ICD-10 Finland

Melaena

1.7

14.3

284

1741

G12.1

ICD-10 Finland

Other inherited spinal muscular atrophy

27.2

14.3

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

14.2

165

862

N19

ICD-10 Finland

Unspecified kidney failure

1.8

14.2

206

1156

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

14.1

406

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

14.1

119

552

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

14.1

193

1064

N05AD03

ATC

melperone; systemic

2.7

14.1

271

K92.0

ICD-10 Finland

Haematemesis

2.1

14.0

131

632

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

6.7

14.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

14.0

153

782

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.4

14.0

SPAT1255

SPAT

Intravenous administration of medicine

1.6

13.9

329

2106

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.6

13.9

313

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

13.9

637

4670

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.4

13.8

141

RF420, ,

NOMESCO Finland

2.7

13.8

285

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

13.8

175

941

F20.5

ICD-10 Finland

Residual schizophrenia

4.0

13.8

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.5

13.8

350

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

13.7

182

992

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

13.7

146

739

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

13.7

873

6747

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.1

13.7

ZXD35

NOMESCO Finland

Usual procedure

1.9

13.7

160

837

M54.1

ICD-10 Finland

Radiculopathy

1.8

13.7

191

1059

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

13.7

106

475

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

13.7

113

520

RF410, ,

NOMESCO Finland

2.8

13.7

247

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.6

13.6

123

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

2.7

13.6

253

A07AA09

ATC

vancomycin; oral

2.5

13.6

328

N19

ICPC

Speech disorder

2.5

13.6

328

G71

ICD-10 Finland

Primary disorders of muscles

75.3

13.6

NJ3CM

NOMESCO Finland

Extensive MRI examination of extremities with 3 Tesla magnet

75.3

13.6

Z99.1

ICD-10 Finland

Dependence on respirator

75.3

13.6

Z43.5

ICD-10 Finland

Attention to cystostomy

3.5

13.6

133

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

12.0

13.6

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

4.9

13.6

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.8

13.6

248

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

13.5

1388

11453

B01AA03

ATC

warfarin; systemic

1.3

13.5

1013

8017

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

13.5

312

1986

L73

ICPC

Fracture: tibia/fibula

2.7

13.5

260

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

10.9

13.5

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.1

13.4

127

616

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.2

13.4

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

6.1

13.4

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

6.1

13.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

13.3

938

7358

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.9

13.3

155

811

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

6.3

13.3

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

5.3

13.2

C10AC01

ATC

colestyramine; oral

2.1

13.2

127

620

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

5.7

13.2

AA400

NOMESCO Finland

Electroconvulsive therapy

3.5

13.2

126

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.8

13.1

184

1021

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

13.1

205

1176

A10BH05

ATC

linagliptin; oral

1.6

13.1

272

1686

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.2

13.1

156

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.2

13.1

156

F05.8

ICD-10 Finland

Other delirium

3.0

13.1

187

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

13.1

915

7168

N94

ICPC

Peripheral neuritis/neuropathy

5.9

13.0

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.4

13.0

384

A10AE04

ATC

insulin glargine; parenteral

1.5

13.0

471

3305

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.6

13.0

300

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.2

13.0

102

460

RK110, ,

NOMESCO Finland

3.2

13.0

152

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

1.9

13.0

158

839

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

12.9

657

4897

A10BA02

ATC

metformin; oral

1.3

12.9

1413

11742

CE2W4

NOMESCO Finland

Eye movement mapping

6.1

12.9

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

4.0

12.9

H50.52

ICD-10 Finland

Exophoria

3.0

12.9

189

R03BB04

ATC

tiotropium bromide; inhalant

1.4

12.9

500

3555

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.4

12.8

133

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.3

12.8

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

12.8

148

772

N88

ICPC

Epilepsy

3.5

12.8

119

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

3.7

12.8

105

IFC04, ,

SPAT

11.5

12.8

K02.1

ICD-10 Finland

Caries of dentine

1.2

12.7

2678

23924

M35.1

ICD-10 Finland

Other overlap syndromes

4.1

12.7

C08CA05

ATC

nifedipine; systemic

1.6

12.7

299

1911

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

12.7

1353

11202

T90

ICPC

Diabetes non-insulin dependent

1.3

12.7

1205

9833

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

5.8

12.7

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

12.7

248

1513

183

Kela drug reimbursment

Lamotrigin and topiramate

3.3

12.7

144

P74

ICPC

Anxiety disorder/anxiety state

1.8

12.7

173

953

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

12.7

162

874

L04AA01

ATC

[U] ciclosporin

2.6

12.7

263

L16

ICPC

Ankle symptom/complaint

1.4

12.6

525

3779

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

12.6

1712

14583

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

12.6

1347

11155

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

12.6

288

1828

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.0

12.6

XCK00

NOMESCO Finland

Perimetry

1.6

12.6

294

1876

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.7

12.6

241

R26.0

ICD-10 Finland

Ataxic gait

4.8

12.6

S06.3

ICD-10 Finland

Focal brain injury

2.5

12.6

293

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

4.6

12.6

L03

ICPC

Low back symptom/complaint

1.3

12.6

1308

10799

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

11.0

12.5

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

12.5

410

SPAT1312

SPAT

General health counselling

1.3

12.5

1392

11587

WYA20

NOMESCO Finland

Home visit

2.1

12.5

112

533

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

12.5

788

6078

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.0

12.5

126

627

NK1AK

NOMESCO Finland

Spectroscopy of muscles

130.3

12.4

E66.8

ICD-10 Finland

Other obesity

1.7

12.4

217

1285

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

12.4

366

2462

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.2

12.4

146

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.9

12.4

188

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

12.3

160

867

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.8

12.3

216

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.0

12.3

132

672

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

12.3

222

1328

C07AB02

ATC

metoprolol; systemic

1.3

12.2

988

7889

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.3

12.2

401

R35

ICD-10 Finland

Polyuria

1.5

12.2

346

2307

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.1

12.2

110

524

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.0

12.2

184

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

12.2

1049

8447

F48.0

ICD-10 Finland

Neurasthenia

9.0

12.2

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

9.6

12.2

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

9.6

12.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

12.1

370

2507

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

15.9

12.1

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

5.5

12.1

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

5.5

12.1

P73

ICPC

Affective psychosis

4.6

12.1

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

12.1

1711

14629

SPAT1127

SPAT

Enema

3.1

12.1

164

NBH10

NOMESCO Finland

Reduction of dislocation of humeroscapular joint, closed

3.5

12.1

119

D12

ICPC

Constipation

1.8

12.0

187

1072

Z29

ICPC

Social problem NOS

2.1

12.0

109

521

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

12.0

168

933

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

8.7

12.0

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

9.3

12.0

S09.9

ICD-10 Finland

Unspecified injury of head

2.3

11.9

374

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

11.9

1010

8116

P80

ICPC

Personality disorder

4.8

11.9

ZXA00

NOMESCO Finland

Right side

1.3

11.9

1236

10195

R06.4

ICD-10 Finland

Hyperventilation

2.6

11.9

272

OAB48, ,

SPAT

0.6

11.8

270

4135

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.4

11.8

L14

ICPC

Leg/thigh symptom/complaint

1.5

11.8

376

2573

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

11.8

278

1780

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.5

11.7

297

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.2

11.7

460

J01CF05

ATC

flucloxacillin; systemic

1.5

11.7

320

2117

S43.0

ICD-10 Finland

Dislocation of shoulder joint

1.8

11.7

180

1028

A02BA02

ATC

ranitidine; systemic

1.3

11.7

896

7099

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.8

11.7

167

933

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.5

11.7

280

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

11.7

200

JN4BD

NOMESCO Finland

Extensive body CT

1.4

11.7

487

3508

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

11.7

146

783

ZXY49

NOMESCO Finland

Other health care provider

4.5

11.6

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

11.6

471

3374

SPAT1244

SPAT

Occupational therapy

2.8

11.6

206

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.0

11.6

168

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

3.7

11.5

E000003, ,

ATC

1.8

11.5

186

1078

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.2

11.5

444

S51.0

ICD-10 Finland

Open wound of elbow

2.4

11.5

312

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

11.5

209

1252

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.7

11.5

224

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

11.5

107

517

G61.9

ICD-10 Finland

Inflammatory polyneuropathy, unspecified

5.7

11.5

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

11.5

182

1050

J01CA08

ATC

pivmecillinam; oral

1.2

11.5

1630

13926

G73.1

ICD-10 Finland

Lambert-Eaton syndrome

+∞

11.5

3592A

ICD-9 Finland

Muscular dystrophies and other myopathies, Myotonic disorders

+∞

11.5

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

5.0

11.5

H49.4

ICD-10 Finland

Progressive external ophthalmoplegia

120.3

11.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.5

11.4

289

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.5

11.4

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

4.7

11.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

11.4

1743

15008

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

11.4

283

1834

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

11.4

116

580

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.4

11.3

A07AA02

ATC

nystatin; oral

1.6

11.3

270

1733

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

2.7

11.3

226

M60.0

ICD-10 Finland

Infective myositis

15.0

11.3

30188

ICD-8 Finland

Personality disorders, Alia definita

3.9

11.3

G44.2

ICD-10 Finland

Tension-type headache

1.4

11.3

546

4036

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

3.7

11.2

N07

ICPC

Convulsion/seizure

4.9

11.2

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

3.8

11.2

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

4.6

11.2

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

11.1

173

992

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

11.1

121

619

R5599

NOMESCO Finland

Other rehabilitation service

1.9

11.1

133

703

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.1

11.1

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.5

11.1

269

I50.0

ICD-10 Finland

Congestive heart failure

1.5

11.1

403

2828

Z10.0

ICD-10 Finland

Occupational health examination

0.5

11.1

122

2260

H02AA02

ATC

fludrocortisone; oral

2.9

11.1

178

R1420, ,

SPAT

3.4

11.1

111

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.2

11.1

131

SPAT1247

SPAT

Outpatient detoxication and monitoring

4.2

11.0

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

3.6

11.0

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.5

11.0

264

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

11.0

155

863

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

11.0

193

1146

L04AD01

ATC

ciclosporin; systemic

2.3

11.0

369

M41.4

ICD-10 Finland

Neuromuscular scoliosis

13.9

10.9

B01AC04

ATC

clopidogrel; oral

1.3

10.9

833

6591

SAA04

NOMESCO Finland

Special examination of mouth

1.7

10.9

220

1354

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

10.9

872

6943

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.5

10.9

RS211, ,

NOMESCO Finland

4.6

10.9

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

3.3

10.9

117

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.0

10.9

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

10.9

454

WX002

NOMESCO Finland

Sedation and analgesia

1.3

10.9

878

7000

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

10.9

106

521

NF3AA

NOMESCO Finland

Femur X-ray examination

2.0

10.9

117

596

IGY02, ,

SPAT

2.5

10.9

260

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

5.4

10.9

K56.0

ICD-10 Finland

Paralytic ileus

2.8

10.8

197

Z28

ICPC

Limited function/disability (Z)

3.4

10.8

113

M48.9

ICD-10 Finland

Spondylopathy, unspecified

3.3

10.8

118

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.5

10.8

267

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

5.1

10.8

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

5.1

10.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

10.8

181

1062

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

3.8

10.7

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

10.7

887

7097

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

17.8

10.7

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

10.7

971

7861

S14.3

ICD-10 Finland

Injury of brachial plexus

4.6

10.7

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

10.7

186

1103

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.3

10.6

324

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

60.1

10.6

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

5.3

10.6

R26

ICD-10 Finland

Abnormalities of gait and mobility

5.3

10.6

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

10.6

138

751

N06AB08

ATC

fluvoxamine; oral

2.0

10.6

115

589

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

2.8

10.6

183

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

10.5

504

3716

29530

ICD-8 Finland

Schizophrenia, Paranoid type

4.2

10.5

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

3.3

10.5

120

M05BX04

ATC

denosumab; parenteral

1.5

10.5

294

1957

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

10.5

299

1998

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

10.5

188

1123

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

10.5

452

3274

F32.8

ICD-10 Finland

Other depressive episodes

2.3

10.5

320

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

4.6

10.5

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3.6

10.5

R31

ICD-10 Finland

Unspecified haematuria

1.4

10.4

513

3799

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

2.7

10.4

201

3590A

ICD-9 Finland

Muscular dystrophies and other myopathies, Congenital hereditary muscular dystrophy

+∞

10.4

G71.14

ICD-10 Finland

Paramyotonia congenita

+∞

10.4

Y34

ICD-10 Finland

Unspecified event, undetermined intent

3.5

10.4

101

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.9

10.4

125

662

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.2

10.4

365

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

10.4

233

1474

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.5

10.3

237

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

10.3

307

2071

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.8

10.3

180

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

10.3

174

1023

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.6

10.3

240

1533

OAB50, ,

SPAT

1.5

10.3

373

2619

G24.0

ICD-10 Finland

Drug-induced dystonia

18.8

10.2

N81

ICPC

Injury nervous system other

4.9

10.2

K29.2

ICD-10 Finland

Alcoholic gastritis

4.9

10.2

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

9.6

10.2

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.2

10.2

407

G04CA02

ATC

tamsulosin; oral

1.2

10.2

1235

10344

RS230, ,

NOMESCO Finland

3.5

10.1

N06AX22

ATC

agomelatine; oral

2.1

10.1

435

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.0

10.1

102

509

A01AB09

ATC

miconazole; local oral

1.4

10.1

373

2628

M05BA07

ATC

risedronic acid; oral

1.8

10.0

140

778

S72.4

ICD-10 Finland

Fracture of lower end of femur

2.8

10.0

177

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

5.0

10.0

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.1

10.0

134

E83.51

ICD-10 Finland

Hypocalcemia

3.1

10.0

134

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

8.4

10.0

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.4

10.0

271

H50.31

ICD-10 Finland

Intermittent exotropia

3.2

10.0

124

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.6

9.9

EBB10

NOMESCO Finland

Insertion of dental implant

2.5

9.9

254

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.3

9.9

322

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

9.8

197

1212

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

3.2

9.8

120

Z00.8

ICD-10 Finland

Other general examinations

1.5

9.8

344

2398

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.1

9.8

S76

ICPC

Skin infection other

1.6

9.8

249

1622

NG1AD

NOMESCO Finland

Knee CT examination

2.2

9.8

368

Z82.6

ICD-10 Finland

Family history of arthritis and other diseases of the musculoskeletal system and connective tissue

20.0

9.8

RK120, ,

NOMESCO Finland

4.4

9.8

GD1QA, ,

SPAT

4.9

9.8

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

9.8

709

5569

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

9.8

191

NCM10

NOMESCO Finland

Fasciotomy of forearm

9.5

9.7

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.4

9.7

256

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

3.5

9.7

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

9.7

352

2470

L18

ICPC

Muscle pain

1.7

9.7

183

1109

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

9.7

309

2114

R07.3

ICD-10 Finland

Other chest pain

1.4

9.7

466

3439

ZXY60

NOMESCO Finland

2-person team, nurses

4.1

9.7

F44.4

ICD-10 Finland

Dissociative motor disorders

13.4

9.7

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

9.6

306

2092

E71.3

ICD-10 Finland

Disorders of fatty-acid metabolism

55.1

9.6

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.2

9.6

364

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

9.6

232

1494

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

5.3

9.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

9.6

2017

17847

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.1

9.6

127

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

9.6

2466

22230

M01AH02

ATC

rofecoxib; oral

1.4

9.6

557

4236

SPAT1138

SPAT

Guidance concerning bowel function

2.2

9.6

352

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.3

9.6

289

A97

ICPC

No disease

1.3

9.6

904

7349

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.0

9.5

138

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

9.1

9.5

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.7

9.5

177

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

3.8

9.5

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.0

9.5

480

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.0

9.5

501

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

9.4

400

SPAT1325

SPAT

Vaccination

1.2

9.4

1549

13381

XA400

NOMESCO Finland

EEG

3.3

9.4

103

29599

ICD-8 Finland

Schizophrenia, Unspecified type

3.7

9.4

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.6

9.4

195

T40.4

ICD-10 Finland

Poisoning: Other synthetic narcotics

17.5

9.4

W17

ICD-10 Finland

Other fall from one level to another

1.7

9.4

184

1127

NJ3BM

NOMESCO Finland

MRI examination of extremities with 3 Tesla magnet

+∞

9.4

73308, ,

ICD-8 Finland

+∞

9.4

G71.2

ICD-10 Finland

Congenital myopathies

+∞

9.4

N17

ICPC

Vertigo/dizziness

1.3

9.3

592

4560

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

5.1

9.3

R06AE07

ATC

cetirizine; oral

1.2

9.3

1904

16790

F60.8

ICD-10 Finland

Other specific personality disorders

3.5

9.3

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

3.1

9.3

119

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

9.3

246

1618

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.9

9.3

104

539

E83.50

ICD-10 Finland

Hypercalcemia

2.3

9.3

293

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

8.7

9.3

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.5

9.3

220

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

9.5

9.2

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.5

9.2

232

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

9.2

198

1240

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

9.2

119

646

Y09

ICD-10 Finland

Assault by unspecified means

3.8

9.2

SPAT1210

SPAT

Application of cast or individual aid

1.7

9.2

170

1025

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.6

9.2

209

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

13.7

9.2

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.9

9.2

120

655

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.3

9.2

276

R81

ICPC

Pneumonia

1.7

9.2

172

1042

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.2

9.1

359

B01AF02

ATC

apixaban; oral

1.3

9.1

671

5278

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

9.1

1193

10060

N05AF01

ATC

flupentixol; systemic

2.2

9.1

327

M04AA01

ATC

allopurinol; systemic

1.3

9.1

655

5137

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

9.1

185

1144

I42.8

ICD-10 Finland

Other cardiomyopathies

3.6

9.1

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

9.1

328

2301

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.1

9.1

400

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

9.1

208

1325

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

11.5

9.0

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

8.3

9.0

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.6

9.0

199

RF432, ,

NOMESCO Finland

36.7

9.0

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.0

9.0

455

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

9.0

300

2073

SPAT1284

SPAT

Extensive health certificate

1.9

9.0

112

602

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

4.1

9.0

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

4.1

9.0

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.8

9.0

125

696

RK220, ,

NOMESCO Finland

3.8

8.9

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.7

8.9

177

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

18.6

8.9

G11.8

ICD-10 Finland

Other hereditary ataxias

18.6

8.9

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

8.9

396

M72.9

ICD-10 Finland

Fibroblastic disorder, unspecified

24.0

8.9

N06AA04

ATC

clomipramine; systemic

2.2

8.9

337

A86

ICD-10 Finland

Unspecified viral encephalitis

3.5

8.9

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.6

8.9

195

F45.0

ICD-10 Finland

Somatization disorder

3.7

8.9

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

8.9

243

1612

F61

ICD-10 Finland

Mixed and other personality disorders

4.3

8.9

D17

ICPC

Incontinence of bowel

2.5

8.8

225

D64.8

ICD-10 Finland

Other specified anaemias

2.0

8.8

479

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

4.9

8.8

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

4.9

8.8

R63.1

ICD-10 Finland

Polydipsia

4.7

8.8

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.8

782

6305

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.9

8.8

107

571

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.0

8.8

H53.3

ICD-10 Finland

Other disorders of binocular vision

3.8

8.8

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

3.2

8.7

103

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.8

8.7

119

658

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

3.7

8.7

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

8.7

281

1929

Z72.0

ICD-10 Finland

Tobacco use

1.9

8.7

109

587

L60.0

ICD-10 Finland

Ingrowing nail

1.6

8.7

205

1315

XA100

NOMESCO Finland

Tensilon test

50.1

8.7

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

4.2

8.6

F25

ICD-10 Finland

Schizoaffective disorders

6.6

8.6

C10AX13

ATC

evolocumab; parenteral

3.1

8.6

109

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.8

8.6

152

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.8

8.6

152

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.9

8.6

141

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

4.4

8.6

TNX30

NOMESCO Finland

Soft bandage, unspecified region

2.3

8.6

284

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

8.6

176

1091

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.3

8.6

259

K11.2

ICD-10 Finland

Sialoadenitis

1.7

8.6

137

795

P27

ICPC

Fear of mental disorder

2.4

8.5

241

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

8.5

161

977

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

8.5

3303

30723

L30.4

ICD-10 Finland

Erythema intertrigo

2.2

8.5

330

ZXE22

NOMESCO Finland

Procedure duration at least 4 but less than 5 hours

6.9

8.5

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

8.5

392

2872

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

3.5

8.5

SPAT1146

SPAT

Puncture of abscess or incision of skin

2.0

8.5

417

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.8

8.5

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.1

8.5

344

RS314, ,

NOMESCO Finland

6.4

8.5

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

8.4

130

746

D01AC02

ATC

miconazole; topical

1.4

8.4

333

2375

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.4

8.4

224

A03FA02

ATC

cisapride; oral, rectal

1.4

8.4

323

2291

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

8.4

198

1269

J02AC01

ATC

fluconazole; systemic

1.2

8.4

1517

13195

R4160, ,

SPAT

3.9

8.4

R15

ICD-10 Finland

Faecal incontinence

1.8

8.4

129

740

Z11

ICPC

Compliance/being ill problem

2.7

8.4

160

G04BD09

ATC

trospium; oral

1.8

8.4

111

609

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.5

8.4

207

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

8.4

214

1399

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

8.4

281

1945

A07DA03

ATC

loperamide; oral

1.7

8.4

147

876

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

4.9

8.3

G41.0

ICD-10 Finland

Grand mal status epilepticus

6.7

8.3

3598X

ICD-9 Finland

Muscular dystrophies and other myopathies, Other myopathies

+∞

8.3

G71.01

ICD-10 Finland

Muscular dystrophy benign scapuloperoneal with early contractures [Emery-Dreifuss]

+∞

8.3

G71.21

ICD-10 Finland

Fibre type disproportion

+∞

8.3

N05BB01

ATC

hydroxyzine; systemic

1.5

8.3

248

1675

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.2

8.3

G83.4

ICD-10 Finland

Cauda equina syndrome

3.7

8.3

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.6

8.3

178

NFQ20

NOMESCO Finland

Amputation of femur

2.6

8.3

178

F06.7

ICD-10 Finland

Mild cognitive disorder

1.7

8.3

151

908

U05

ICPC

Urination problems other

1.5

8.3

252

1709

D07XC01

ATC

betamethasone; topical

1.3

8.3

526

4052

IHZ04, ,

SPAT

2.2

8.3

295

ECB00

NOMESCO Finland

Suture of gingiva

1.7

8.3

158

962

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

8.3

304

2140

A05

ICPC

Feeling ill

1.5

8.3

228

1515

RK320, ,

NOMESCO Finland

2.6

8.3

167

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.0

8.3

408

S01

ICD-10 Finland

Open wound of head

2.2

8.2

283

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

3.5

8.2

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3788

15787

5.42

307.65

5.1

2.2

1447.20

175.31

u/l

46.33

3659

14918

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1543

1843

11.21

307.65

3.0

2.2

1874.64

366.60

ug/l

13.01

1472

1750

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

419

251

17.98

307.65

1.3

1.1

13.49

0.11

nmol/l

8.57

199

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

322

257

13.24

307.65

1.9

1.4

8.82

6.13

u/l

1.62

269

222

(3023368) Bacteria identified in Blood by Culture

2755

14893

2.69

278.78

5.6

4.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1614

7090

2.80

239.67

6.3

1.06

1.04

mmol/l

1.37

1501

6606

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3851

25658

2.64

236.87

10.5

7.6

1.20

1.21

mmol/l

6.85

3379

22200

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1853

8793

2.66

235.62

3.7

3.6

0.80

0.81

mmol/l

3.91

1722

8263

(3023183) Ammonium ion [Moles/volume] in Plasma

535

1155

5.02

233.56

3.1

2.8

31.14

34.61

umol/l

2.04

478

1045

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3550

23012

2.51

227.25

9.9

7.0

1.20

1.21

mmol/l

10.47

3348

21282

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1840

9031

2.55

214.71

2.3

2.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

996

3652

3.11

202.46

5.3

4.1

5.25

5.15

kpa

2.93

955

3486

(3009343) pH of Capillary blood

975

3551

3.12

200.37

5.3

4.1

7.41

7.42

2.37

848

2940

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

886

3123

3.19

192.02

5.0

4.0

1.69

1.85

mmol/l

0.58

702

2297

(3024561) Albumin [Mass/volume] in Serum or Plasma

3403

22842

2.27

183.16

5.9

5.3

33.71

35.33

g/l

40.63

3152

21375

(3013826) Glucose [Moles/volume] in Serum or Plasma

3984

29368

2.27

158.91

8.2

5.3

6.79

6.78

mmol/l

0.04

3878

27981

(3032080) INR in Blood by Coagulation assay

3409

24046

2.08

146.46

17.5

17.1

1.26

1.30

inr

4.98

2929

20235

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

434

1150

4.01

144.24

1.4

1.2

2.10

11.36

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

198

257

7.95

143.34

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1671

9112

2.19

142.52

2.0

1.8

1194.82

1155.76

nmol/l

0.87

1254

6902

(3006315) Basophils [#/volume] in Blood

3470

24879

2.05

139.38

9.3

6.3

0.04

e9/l

2.63

3083

21201

(3020779) Urea [Moles/volume] in Serum or Plasma

1100

5064

2.46

139.33

7.7

7.6

11.55

10.38

mmol/l

4.20

1046

4846

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3597

26136

2.07

139.15

7.3

6.8

11.59

12.18

umol/l

1.51

3414

24948

(3014111) Lactate [Moles/volume] in Serum or Plasma

1079

4938

2.47

138.36

9.0

7.9

1.50

1.34

mmol/l

4.06

1056

4835

(3001604) Monocytes [#/volume] in Blood

3459

24809

2.05

138.31

9.3

6.3

0.62

0.60

e9/l

3.80

3074

21123

(3013115) Eosinophils [#/volume] in Blood

3540

25603

2.06

138.30

9.8

6.5

0.18

0.19

e9/l

3.48

3145

22167

(3022313) Gas panel - Capillary blood

686

2502

2.99

137.65

5.7

4.3

—

(3019069) Monocytes/Leukocytes in Blood

3257

22949

2.02

135.82

9.7

6.7

8.94

9.02

0.78

3096

21491

(3031040) Bacteria [#/volume] in Urine by Automated count

4120

31634

2.18

135.64

6.8

5.0

1278.57

2033.28

e6/l

0.52

491

(3006504) Eosinophils/Leukocytes in Blood

3247

22887

2.01

134.85

9.6

6.6

2.58

2.86

10.58

3087

21424

(3022096) Basophils/Leukocytes in Blood

3244

22869

2.01

134.54

9.7

6.7

0.62

0.67

5.42

3083

21399

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

583

1965

3.20

133.97

5.9

4.5

24.72

24.79

mmol/l

0.18

538

1798

(3019198) Lymphocytes [#/volume] in Blood

3495

25363

2.02

132.60

9.5

6.4

1.78

1.89

e9/l

1.91

3145

22135

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2857

19364

1.98

131.61

6.1

4.1

64.30

81.38

ng/l

0.33

2430

14286

(3002030) Lymphocytes/Leukocytes in Blood

3272

23415

1.97

126.58

9.6

6.6

25.08

27.10

20.58

3135

22160

(3018010) Neutrophils/Leukocytes in Blood

3227

22994

1.97

126.32

9.4

6.5

59.83

57.73

17.86

3101

21930

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1312

6772

2.23

126.04

2.1

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2188

13723

1.98

124.16

2.7

2.4

3.08

2.86

mg/l

3.94

1845

11907

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3159

22464

1.94

123.03

2.6

2.2

93.29

95.03

pmol/l

1.19

1877

12043

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2475

16292

1.94

120.87

3.7

3.3

1926.95

1608.86

ng/l

1.72

2119

14166

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1137

5653

2.27

118.86

5.8

4.0

5.90

5.82

kpa

1.72

1101

5504

(3021960) Folate [Moles/volume] in Serum or Plasma

2296

14802

1.94

118.75

2.0

1.7

18.59

20.04

nmol/l

4.91

1964

12574

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2405

15863

1.91

115.04

3.4

2.7

60.42

65.56

u/l

0.47

2229

14718

(3013650) Neutrophils [#/volume] in Blood by Automated count

3669

27787

1.95

114.30

13.1

9.7

4.55

4.20

e9/l

11.76

3278

23951

(3036481) Cortisol [Moles/volume] in Serum or Plasma

971

4589

2.35

113.91

2.3

361.88

378.86

nmol/l

1.66

893

4242

(3012544) pH of Venous blood

1130

5753

2.21

110.65

5.9

4.1

7.37

7.38

1.62

733

3372

(3022948) Iron [Moles/volume] in Serum or Plasma

1570

9059

2.02

110.38

2.9

2.7

11.32

12.68

umol/l

11.56

1411

8443

(3002032) Base excess in Venous blood by calculation

1096

5519

2.23

110.23

5.9

4.1

1.87

1.84

mmol/l

0.12

966

4812

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4518

37073

2.18

109.16

10.9

8.5

81.51

80.77

u/l

0.45

4321

35179

(3037522) Nuclear Ab [Titer] in Serum

1202

6406

2.12

104.01

1.4

1.3

625.74

498.98

titre

1.45

317

1357

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

517

1878

2.93

103.37

2.2

1.8

—

(3019977) pH of Arterial blood

1199

6416

2.11

102.47

9.3

7.9

7.41

7.42

0.45

730

3546

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1199

6427

2.10

101.94

9.3

7.9

5.18

5.09

kpa

1.90

1161

6167

(3027801) Oxygen [Partial pressure] in Arterial blood

1198

6426

2.10

101.64

9.3

7.8

11.39

12.24

kpa

7.79

1158

6165

(3003396) Base excess in Arterial blood by calculation

1187

6389

2.09

99.55

9.2

7.8

1.40

0.92

mmol/l

3.00

1003

5217

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

537

2034

2.82

99.23

2.3

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

813

3776

2.35

98.18

2.8

2.9

10.30

10.59

g/l

1.05

752

3472

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1459

8494

1.97

98.13

2.9

2.7

2.24

2.29

g/l

1.88

1313

7853

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

226

488

4.79

97.45

1.2

68.42

49.79

u/ml

0.32

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2984

21797

1.80

96.76

3.1

2.5

74.72

77.91

nmol/l

6.50

2657

19602

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1370

7841

1.99

96.56

2.9

2.7

20.41

22.29

5.63

1238

7298

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

570

2265

2.69

95.90

2.2

1.9

2.30

2.39

ug/l

0.06

473

2007

(3015235) Bicarbonate [Moles/volume] in Capillary blood

511

1923

2.83

95.47

3.4

3.2

25.08

24.80

mmol/l

0.86

506

1894

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

988

5037

2.17

95.00

2.5

2.3

0.19

0.21

g/l

4.82

895

4702

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1023

5294

2.14

94.63

2.4

1.8

1.73

1.51

11.05

863

4611

(3020630) Protein [Mass/volume] in Serum or Plasma

929

4632

2.21

94.42

2.1

2.6

64.66

66.20

g/l

6.77

828

4223

(3020191) Ethanol [Moles/volume] in Serum or Plasma

199

397

5.16

94.14

2.0

1.4

1.34

1.25

promille

0.31

172

317

(3024354) Oxygen [Partial pressure] in Venous blood

944

4746

2.19

93.93

5.4

3.5

4.60

4.52

kpa

0.46

904

4610

(3009466) Valproate [Moles/volume] in Serum or Plasma

268

687

4.05

92.66

5.9

5.1

347.68

351.44

umol/l

0.15

236

606

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1157

6326

2.05

92.18

3.2

4.5

260.15

245.80

u/l

2.28

1077

5983

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

807

3858

2.28

90.59

2.0

1.7

—

(3019225) pH of Specimen

939

4782

2.16

90.13

5.9

4.5

7.37

7.35

3.81

760

3427

(3007853) Bacteria identified in Skin by Aerobe culture

1093

5897

2.06

90.09

2.3

1.8

—

(3018418) pH of Serum or Plasma

2261

15477

1.78

89.09

5.4

4.3

7.40

0.23

1723

11196

(3016502) Oxygen saturation in Arterial blood

1072

5769

2.06

88.84

9.6

8.1

94.83

95.51

2.15

1035

5564

(3000991) Gas panel - Venous blood

937

4797

2.15

88.60

11.4

9.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1143

6364

2.00

85.87

2.2

1.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

707

3307

2.30

83.15

6.5

4.2

24.03

24.17

mmol/l

0.52

693

3269

(3027945) Reticulocytes/Erythrocytes in Blood

1135

6450

1.96

79.70

2.4

2.6

1.83

1.79

0.66

953

5735

(3013637) Mi-2 Ab [Presence] in Serum

108

138

7.96

79.11

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

108

138

7.96

79.11

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

108

138

7.96

79.11

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

108

138

7.96

79.11

1.1

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2425

17393

1.70

77.56

3.3

3.6

2.33

2.35

mmol/l

9.53

2167

15762

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

386

1396

2.90

77.24

2.7

1.5

0.22

0.24

g/l

2.69

374

1329

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

393

1439

2.86

76.86

2.7

1.6

1.16

1.19

g/l

1.15

378

1371

(3023420) DNA double strand Ab [Units/volume] in Serum

468

1886

2.62

75.97

2.6

1.7

10.23

6.33

iu/ml

1.89

137

451

(3023520) Reticulocytes [#/volume] in Blood

925

4992

2.02

74.86

2.4

2.7

67.44

68.53

e9/l

0.42

683

3661

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2912

22061

1.67

74.62

3.7

3.1

158.58

139.78

ug/l

2.93

2646

20524

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

603

2757

2.33

74.38

1.7

1.5

—

(3026782) Osmolality of Urine

1570

10071

1.78

74.27

3.8

3.0

509.56

534.68

mosm/kgh2o

5.12

1433

8845

(3002582) Erythrocytes [#/volume] in Urine

2345

16873

1.68

72.60

4.6

3.5

45.35

87.44

e6/l

3.51

1934

12950

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

347

1228

2.95

72.15

1.5

1.4

557.00

561.67

mg/l

0.04

333

1163

(3000850) Epithelial cells [#/volume] in Urine

1753

11716

1.73

71.16

3.6

2.8

5.41

5.11

e6/l

0.43

1650

10676

(3021601) Nitrite [Presence] in Urine by Test strip

3231

25344

1.66

70.62

5.0

4.0

0.00

estimate

1.60

735

5402

(3035350) Ketones [Presence] in Urine by Test strip

3254

25632

1.65

69.38

5.0

4.1

17.75

4.07

estimate

1.62

741

5551

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

27.87

69.36

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

420

1682

2.62

68.89

1.4

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

3269

25809

1.65

68.81

5.0

4.1

0.00

0.07

estimate

0.66

708

5179

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

132

245

5.49

67.63

20.3

19.3

12905.29

1400.31

nmol/l

0.49

127

236

(3018095) Leukocytes [#/volume] in Urine

2533

18824

1.64

67.45

5.4

4.2

96.92

98.25

e6/l

0.03

1969

13468

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

313

1086

2.99

67.35

1.4

3.97

3.79

mmol/l

1.81

293

1021

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4157

35131

1.73

65.62

6.0

4.5

15.39

12.78

mm/h

18.13

3858

32783

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

844

4606

1.98

65.47

2.8

2.4

13.09

7.57

ug/l

4.13

677

4049

(3028026) IgM [Mass/volume] in Serum or Plasma

612

2972

2.19

64.90

1.9

2.0

1.14

1.36

g/l

2.34

564

2714

(1616796) Gas panel - Central venous blood

330

1203

2.85

64.89

4.3

4.0

—

(3015736) pH of Urine

2693

20445

1.62

64.82

4.4

3.6

6.29

6.24

1.40

1426

11359

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

304

1077

2.93

62.97

1.4

1.2

11.89

5.26

u/ml

0.33

(3030467) Casts [#/volume] in Urine by Automated count

2043

14580

1.64

62.66

4.6

3.4

0.54

0.44

e6/l

0.97

1635

10780

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

352

1357

2.70

62.17

1.4

1.2

44.07

38.04

u/ml

0.17

(3002173) Hemoglobin [Mass/volume] in Arterial blood

929

5334

1.89

61.62

10.7

8.6

121.73

121.02

g/l

0.47

912

5209

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2202

16066

1.61

61.36

4.4

3.4

46.77

36.23

u/l

5.05

2059

15150

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

337

1283

2.73

60.98

1.4

1.3

4.77

3.07

u/ml

0.52

114

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3722

30826

1.63

60.48

5.2

3.4

66.05

51.52

u/l

8.26

3486

28810

(36304419) Bacteria [Presence] in Urine

1948

13849

1.63

60.02

4.4

3.4

0.29

234.32

estimate

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

335

1284

2.71

59.81

1.4

1.3

5.99

7.98

u/ml

0.26

196

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

121

235

5.24

58.98

15.6

14.9

9021.22

818.94

nmol/l

0.49

116

226

(3003181) Sodium [Moles/volume] in Urine

288

1029

2.90

58.71

1.5

1.4

60.89

62.47

mmol/l

0.23

219

838

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

640

3309

2.06

57.28

10.4

9.8

24.67

24.23

mmol/l

2.03

620

3234

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

686

3642

2.01

57.04

9.4

8.7

24.85

24.86

mmol/l

0.00

677

3618

(3028707) Methadone [Presence] in Urine by Screen method

209

630

3.41

56.82

3.8

2.9

—

(3045424) Erythrocytes [Presence] in Urine

513

2446

2.21

56.64

2.4

2.2

0.00

0.35

estimate

0.54

100

754

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1570

10702

1.65

56.51

2.0

1.8

1.60

1.35

mg/l

1.56

1234

8359

(3014576) Chloride [Moles/volume] in Serum or Plasma

1185

7509

1.74

56.05

10.2

7.4

103.83

104.32

mmol/l

2.36

1185

7504

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

737

4038

1.95

55.90

4.2

4.1

94.27

93.42

ng/l

0.08

622

3458

(3042936) Bacteria identified in Isolate by Culture

1165

7360

1.74

55.65

2.6

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

1969

14264

1.59

54.85

5.2

4.2

0.00

estimate

1.98

652

4889

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4125

35393

1.65

54.73

5.1

4.3

15.06

14.88

pmol/l

4.18

3773

32312

(3015171) Extractable nuclear Ab [Units/volume] in Serum

397

1722

2.41

54.68

1.4

1.2

2.15

0.92

u/ml

0.40

146

(3014271) Vancomycin [Susceptibility]

123

262

4.78

53.87

4.0

3.0

—

(3044640) Blood type and Crossmatch panel - Blood

2163

16070

1.57

53.70

3.1

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

119

250

4.84

52.99

2.5

2.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

173

485

3.65

52.54

1.6

1.5

—

(3012501) Base excess in Blood by calculation

285

1074

2.74

52.51

5.4

4.5

2.53

2.65

mmol/l

0.31

210

734

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

529

2628

2.12

52.48

1.7

1.66

1.54

g/l

2.13

445

2259

(3013290) Carbon dioxide [Partial pressure] in Blood

285

1075

2.74

52.42

5.4

4.5

5.00

5.02

kpa

0.22

276

1052

(3027315) Oxygen [Partial pressure] in Blood

286

1081

2.74

52.39

5.4

4.6

8.58

8.45

kpa

0.55

277

1057

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1252

8189

1.68

52.20

2.4

2.2

29.66

29.83

0.50

1211

7958

(3045414) Leukocytes [Presence] in Urine

816

4786

1.83

49.71

2.4

2.2

0.00

0.01

estimate

0.78

140

992

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

109

227

4.88

49.06

2.1

154.02

102.10

umol/l

0.72

127

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1525

10627

1.60

48.85

1.8

18952057.12

28537820.76

pmol/l

0.36

1240

8813

(3021901) Oxygen saturation in Capillary blood

293

1167

2.59

48.33

3.5

3.1

90.03

89.22

1.16

288

1138

(44816559) Phosphatidylethanol [Mass/volume] in Blood

422

1979

2.23

48.32

2.0

1.7

0.34

0.32

mg/l

0.35

209

933

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

276

1068

2.67

48.26

1.7

1.5

12.50

26.80

e6/l

0.90

219

786

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

277

1087

2.63

47.09

1.7

1.5

1343.87

1095.94

e6/l

0.14

230

857

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

403

1874

2.24

47.08

2.6

3.4

36.83

57.70

mg/l

1.60

337

1598

(3034860) Kappa light chains.free [Mass/volume] in Serum

403

1877

2.24

46.89

2.6

3.4

49.73

85.75

mg/l

0.66

336

1598

(3020891) Body temperature

495

2520

2.06

45.79

6.3

4.5

36.93

36.91

°c

0.76

489

2491

(3009445) Proteinase 3 Ab [Units/volume] in Serum

440

2146

2.14

45.59

1.3

1.6

17.02

15.53

iu/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1695

12265

1.55

45.43

2.9

2.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

618

3410

1.91

45.37

9.5

6.9

24.49

24.47

mmol/l

0.04

602

3261

(3003129) Base excess in Capillary blood by calculation

187

608

3.15

44.94

2.9

2.3

1.19

0.39

mmol/l

1.83

181

586

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

388

1839

2.19

43.17

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1328

9183

1.59

43.03

1.6

1.5

2.45

2.52

g/l

0.62

843

5561

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

363

1688

2.23

42.32

2.6

3.2

3.32

3.59

ratio

0.06

207

979

(3017143) Hepatitis C virus Ab [Presence] in Serum

813

5008

1.73

41.29

1.7

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

633

3623

1.84

41.26

11.9

9.9

93.14

93.92

1.85

627

3612

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

190

657

2.96

41.05

1.3

1.1

2.31

7.69

u/ml

0.79

(3010421) pH of Blood

357

1671

2.21

40.94

5.2

4.0

7.41

0.82

348

1650

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

422

2121

2.07

40.28

1.8

2.3

2.98

2.93

g/l

0.46

365

1912

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4964

45710

1.82

40.23

31.4

17.6

28.11

25.65

mg/l

6.12

4600

38199

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1435

10262

1.54

39.51

3.0

3.1

2.46

mmol/l

0.29

1249

9165

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4664

42280

1.65

39.30

6.5

5.3

1.91

1.95

mu/l

1.38

4338

38866

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

441

2273

2.02

39.27

1.7

2.3

7.34

7.43

g/l

0.49

383

2063

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

441

2273

2.02

39.27

1.7

2.3

4.15

4.19

g/l

0.59

384

2062

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

132

379

3.54

38.72

1.3

2.18

2.17

mmol/l

0.05

118

355

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

2271

2.01

38.68

1.7

2.3

3.60

3.73

g/l

1.01

382

2063

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

232

4.33

38.57

1.7

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

506

2761

1.92

38.16

5.1

4.1

49.05

47.86

0.51

492

2716

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1420

10196

1.53

38.13

5.2

4.1

260.81

483.51

ng/l

1.46

1201

8333

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

943

6162

1.64

38.03

1.7

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

240

976

2.53

37.88

5.4

3.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

468

2495

1.96

37.80

4.2

3.5

25.13

25.24

mmol/l

0.28

455

2408

(3004616) Nuclear Ab [Presence] in Serum

170

579

3.00

37.74

1.4

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

599

3462

1.82

37.66

5.7

3.4

128.81

128.50

g/l

0.12

581

3358

(3017732) Neutrophils [#/volume] in Blood

933

6103

1.64

37.42

4.8

3.3

5.00

4.70

e9/l

0.42

749

5240

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

390

1965

2.06

36.92

1.9

2.3

0.60

0.97

g/l

1.41

328

1664

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.73

36.88

2.0

2.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1069

7255

1.59

36.74

1.9

1.8

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

150

485

3.15

36.42

1.1

—

3.05

—

(3013512) EKG study

2187

17235

1.44

36.36

4.9

3.9

1.00

0.74

—

(3033658) Prothrombin time (PT) actual/Normal

1703

12795

1.48

36.35

6.1

4.4

87.23

87.18

0.02

1658

12523

(1001926) Buprenorphine [Presence] in Urine by Screen method

262

1131

2.38

36.31

3.8

2.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

401

2055

2.03

36.22

1.7

1.9

39.61

39.39

u/l

0.07

354

1813

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

6.61

35.67

2.0

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

385

1962

2.03

35.30

1.8

2.3

9.93

10.30

g/l

0.78

324

1734

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

116

328

3.59

34.85

1.1

352.68

293.79

mg/l

0.70

107

280

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

303

1423

2.19

34.40

1.6

1.4

12.52

15.29

iu/ml

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

159

4.83

34.09

2.4

141.95

151.00

nmol/l

0.33

141

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

233

982

2.43

34.06

1.4

1.2

45.15

45.74

u/ml

0.02

(3019550) Sodium [Moles/volume] in Serum or Plasma

5029

46871

1.78

33.88

36.8

21.1

139.34

139.63

mmol/l

10.09

4978

45952

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

117

340

3.49

33.73

1.2

1.1

46.93

43.11

mg/l

0.24

106

280

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

543

3166

1.79

32.98

2.5

2.4

16.99

21.42

au/ml

0.65

314

(3002179) Metamyelocytes/Leukocytes in Blood

697

4360

1.68

32.94

4.4

4.3

0.95

0.72

0.67

298

1360

(3016018) Differential panel - Cerebral spinal fluid

155

542

2.91

32.86

1.9

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

131

417

3.19

32.68

1.3

1.2

88.44

69.15

u/ml

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5030

46965

1.76

32.56

37.1

21.3

3.98

3.99

mmol/l

0.72

4982

45967

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

108

305

3.59

32.53

1.1

—

(4198724) Urine methamphetamine measurement

182

4.45

32.41

2.1

3.0

—

(3037756) Immunofixation for Serum or Plasma

256

1150

2.29

32.36

1.5

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

873

5804

1.60

32.33

4.8

5.1

32.44

32.50

0.05

613

3795

(3024928) Oxygen saturation in Venous blood

295

1409

2.16

32.09

6.4

3.4

63.33

60.92

1.04

269

1366

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

874

5832

1.59

31.83

3.3

2.9

9.14

9.08

umol/l

0.03

744

5127

(3014148) Varicella zoster virus Ab [Titer] in Serum

151

536

2.87

31.16

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2711

22588

1.39

31.09

3.3

2.9

—

estimate

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

273

3.67

30.90

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

501

2907

1.80

30.86

1.4

1.3

64.92

52.97

au/ml

0.36

201

(3016879) Cocaine [Presence] in Urine

281

1343

2.15

30.51

4.0

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

295

1438

2.11

30.44

3.8

2.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1258

9166

1.48

30.36

3.9

3.1

1.15

1.09

e6/l

0.27

745

4930

(3021589) Normoblasts [#/volume] in Blood

2577

21388

1.38

29.75

18.0

12.1

0.00

e9/l

0.06

2133

17357

(3028300) Cannabinoids [Presence] in Urine

293

1450

2.08

29.04

3.9

2.2

—

(3008295) Osmolality of Serum or Plasma

158

598

2.69

28.89

1.4

281.76

277.60

mosm/kgh2o

0.96

128

440

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

126

423

3.02

28.75

1.1

—

(3027008) Opiates [Presence] in Urine

291

1444

2.07

28.63

3.9

2.0

—

(3052851) Hemolysis interference index of Serum or Plasma

281

1377

2.10

28.59

3.9

3.4

1.71

1.95

index

0.32

140

722

(3017181) Myelocytes/Leukocytes in Blood

704

4573

1.62

28.45

4.7

4.4

0.93

0.95

0.08

286

1439

(3024666) Lithium [Moles/volume] in Serum or Plasma

215

3.86

27.55

15.4

12.6

0.63

0.62

mmol/l

0.12

197

(3025159) Blasts/Leukocytes in Blood

678

4397

1.62

27.52

5.2

4.6

0.14

0.26

0.41

248

1170

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

520

3149

1.72

27.49

13.8

10.4

16.03

15.93

0.34

506

3036

(3042517) Benzodiazepines panel - Urine

10.05

27.37

2.1

2.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

309

1593

2.00

27.36

1.9

2.3

0.00

g/l

0.50

270

1386

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

213

3.84

27.11

1.1

1781.16

1488.48

miu/ml

1.41

213

(3018405) Lactate [Moles/volume] in Arterial blood

336

1790

1.93

27.04

5.3

3.9

1.43

1.40

mmol/l

0.13

330

1761

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

842

5776

1.54

26.76

11.7

7.4

—

(3021440) Promyelocytes/Leukocytes in Blood

672

4378

1.61

26.73

4.8

4.4

0.09

0.12

0.54

253

1245

(3039162) Centromere protein B Ab [Units/volume] in Serum

148

565

2.66

26.63

1.4

1.2

32.25

54.96

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

180

755

2.43

26.62

7.7

6.6

11.56

12.07

mg/l

0.69

161

701

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2310

19062

1.36

26.57

5.2

4.1

0.18

0.29

estimate

0.21

625

4436

(3017354) Segmented neutrophils/Leukocytes in Blood

148

566

2.66

26.53

3.2

3.8

62.39

57.05

2.19

120

484

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

285

1448

2.02

26.28

1.4

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

111

365

3.08

26.28

1.3

1.2

32.35

52.78

u/ml

—

(3044927) Protein electrophoresis panel - Urine

141

531

2.70

26.06

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

226

1057

2.19

25.92

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

226

1057

2.19

25.92

1.4

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

7.70

25.90

1.4

2.4

—

(3047181) Lactate [Moles/volume] in Blood

307

1611

1.96

25.82

7.9

6.1

1.52

1.33

mmol/l

1.81

267

1429

(3007566) Smooth muscle Ab [Titer] in Serum

270

1354

2.04

25.81

1.2

1.3

117.74

104.39

titre

0.13

123

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

288

1484

1.99

25.53

1.9

2.3

0.00

g/l

-0.00

270

1384

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

340

1863

1.88

25.11

3.7

3.4

0.30

0.34

iu/ml

1.88

183

1041

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

311

1657

1.93

25.01

1.9

2.2

0.01

0.03

g/l

1.55

281

1477

(3006653) Thiamine [Moles/volume] in Blood

256

3.44

24.69

1.2

146.28

134.99

nmol/l

1.06

256

(3006184) Hemoglobin [Mass/volume] in Capillary blood

260

1310

2.03

24.54

2.6

2.3

130.65

128.47

g/l

0.73

220

1014

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1142

8461

1.44

24.53

4.1

3.3

3.15

2.24

e6/l

2.17

631

4204

(3023410) Appearance of Cerebral spinal fluid

128

474

2.74

24.46

2.0

1.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

239

3.51

24.36

1.1

1.05

1.16

u/l

0.41

114

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1360

10415

1.41

24.22

1.4

1.3

1.50

1.82

u/ml

0.50

304

2729

(3037121) Protein [Mass/volume] in Urine

327

1792

1.88

24.13

3.1

3.3

493.24

388.49

mg/l

0.29

165

818

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

246

3.45

24.03

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

531

2.62

23.95

3.4

4.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

662

4406

1.57

23.90

3.1

3.2

223.37

221.99

ng/l

0.02

602

4020

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

454

2750

1.71

23.89

3.1

3.4

4.35

4.47

pmol/l

1.58

388

2446

(4027681) Cerebrospinal fluid IgG ratio and IgG index

247

3.44

23.88

1.2

0.54

0.58

ratio

0.57

139

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

302

3.18

23.84

2.7

2.9

225.56

215.90

e6/l

0.17

258

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

761

5230

1.53

23.77

5.1

3.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

214

4215

0.49

23.75

1.9

2.0

3.51

3.53

ratio

0.08

179

3303

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

104

352

2.99

23.46

1.6

1.3

—

(40758558) Short blood count panel - Blood

1836

14826

1.36

23.43

8.7

6.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

232

3.48

23.24

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

232

3.48

23.24

1.7

1.4

—

(3027944) Amphetamines [Presence] in Urine

272

1426

1.95

22.94

3.5

2.2

—

(3034770) Mitochondria Ab [Titer] in Serum

259

1339

1.98

22.75

1.2

962.50

1130.91

titre

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

173

769

2.29

22.47

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

345

2.96

22.43

1.6

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1509

11887

1.37

22.33

4.8

3.9

0.38

0.16

—

144

(3000570) Elastase.pancreatic [Mass/mass] in Stool

288

1556

1.90

22.21

1.4

264.32

275.48

ug/g

0.40

160

942

(3016038) Potassium [Moles/volume] in Urine

107

381

2.84

22.05

1.3

33.28

35.49

mmol/l

0.46

336

(3004809) Band form neutrophils/Leukocytes in Blood

191

896

2.17

21.78

3.2

3.8

1.17

1.55

0.96

162

797

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

206

3.53

21.38

2.1

1.4

4339794.63

1176621.36

iu/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

130

4.26

21.32

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

408

2483

1.69

21.06

7.3

5.2

1.64

1.60

0.33

383

2342

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

610

4098

1.55

21.01

5.5

4.1

1.21

1.23

mmol/l

3.64

542

3567

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

195

3.57

20.88

1.2

1.1

404.32

190.98

ng/l

0.28

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

195

939

2.12

20.81

1.3

377.14

349.11

titre

0.05

(1761868) Lipid panel - Serum or Plasma

1325

16640

0.73

20.71

3.5

3.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

698

4843

1.50

20.66

3.2

2.5

71.43

48.36

u/l

0.32

584

4088

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

282

1551

1.86

20.58

3.7

4.2

1.80

1.59

mg/l

2.33

256

1414

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

144

616

2.37

20.46

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

145

623

2.36

20.40

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

145

623

2.36

20.40

4.8

16.3

6.90

7.36

mmol/l

1.06

124

529

(3011412) CD3 cells [#/volume] in Blood

116

452

2.60

20.12

2.5

1136.46

1124.18

e6/l

0.06

103

401

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

145

627

2.35

20.11

1.5

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

2099

17574

1.31

20.02

3.9

3.5

6.98

7.53

mmol/l

6.99

1754

14826

(3024869) Neuronal Ab [Presence] in Serum

5.03

19.94

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

172

805

2.17

19.75

1.6

0.62

0.84

g/l

2.69

135

628

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

245

1305

1.92

19.74

1.4

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

134

4.06

19.65

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.55

19.58

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

301

2.95

19.55

2.6

0.65

e9/l

0.00

287

(3025468) Yersinia sp identified in Specimen by Organism specific culture

138

593

2.36

19.43

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

138

595

2.35

19.28

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

138

597

2.35

19.14

1.5

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

7.91

19.14

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

305

2.92

19.10

2.8

2.7

487.06

529.57

e6/l

0.31

246

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

217

1124

1.97

18.99

1.7

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

142

3.90

18.98

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

509

3361

1.57

18.86

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

319

1873

1.75

18.73

2.6

2.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

7.03

18.64

1.4

1.1

10.64

9.85

u/l

0.09

(3030981) Hyaline casts [#/volume] in Urine by Automated count

626

4344

1.50

18.42

2.8

2.5

0.50

0.49

e6/l

0.07

607

4176

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

233

3.16

18.28

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1321

10460

1.35

18.26

6.6

4.8

—

(4035726) Immunohistochemistry procedure

623

4330

1.49

18.18

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

422

2.57

18.14

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

121

506

2.42

18.12

2.6

3.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

152

3061

0.48

17.87

1.6

1.7

3.46

3.44

mmol/l

0.06

113

2138

(40768797) Stomach Pathology biopsy report

897

6734

1.40

17.22

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

221

3.15

17.20

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

3.83

17.20

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

249

1395

1.82

17.15

1.6

1.7

—

(1175426) CD3 cells/Lymphocytes in Blood

364

2.64

17.10

2.2

2.3

76.88

71.67

3.68

345

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

125

545

2.32

17.07

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

244

1363

1.83

16.97

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

232

1277

1.85

16.92

1.9

2.0

12.53

12.26

mg/l

0.13

217

1185

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

1173

1.88

16.75

1.3

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

382

2.57

16.53

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

800

5933

1.41

16.44

1.7

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5062

48463

1.51

16.36

37.7

23.1

82.63

80.75

umol/l

2.03

5028

47836

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.18

16.24

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

135

627

2.18

15.88

2.5

2.1

25.88

24.52

mg/l

0.11

220

(40761536) Microorganisms panel - Urine sediment

547

3803

1.49

15.86

5.5

4.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

140

660

2.15

15.86

2.3

2.4

1.24

1.27

g/24h

0.06

390

(3041096) Erythrocytes [Presence] in Urine by Automated

1620

13422

1.29

15.75

4.4

3.5

0.06

0.17

estimate

0.59

578

4232

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

161

804

2.03

15.67

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

115

505

2.30

15.49

1.7

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

372

2.53

15.38

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

377

2435

1.59

15.32

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

258

1520

1.73

15.00

1.8

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

359

2.53

14.98

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.39

14.93

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

244

1419

1.75

14.85

1.4

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

367

2.50

14.81

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

367

2.50

14.81

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1388

11355

1.30

14.68

5.4

4.3

1.02

1.15

kg/l

0.50

1013

7668

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

256

1517

1.72

14.58

1.6

1.5

10.45

7.43

iu/ml

0.11

293

(3033099) Centromere Ab [Titer] in Serum

4.23

14.31

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4615

43661

1.34

14.30

27.1

17.4

79.53

78.42

ml/min/173m2

2.26

4365

40573

(3022493) Free Hemoglobin [Mass/volume] in Plasma

227

2.89

14.02

1.1

5.2

68.93

69.67

mg/l

0.03

163

(21494755) Public health laboratory ask at order entry panel

202

3451

0.57

13.84

1.3

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4995

47910

1.43

13.80

18.1

12.6

30.89

26.35

u/l

18.66

4872

46435

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

860

1.92

13.61

2.6

3.0

776.20

1455.36

u/ml

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

177

961

1.87

13.54

1.6

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

173

3.14

13.53

2.9

2.8

27.08

29.37

umol/l

0.62

127

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

990

1.86

13.53

1.3

1.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

347

2.47

13.52

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

354

2.45

13.44

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

386

2.38

13.32

1.3

1.2

106.03

104.06

pmol/l

0.15

386

(36660697) Celiac disease serology panel - Serum

521

3713

1.44

13.24

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.11

13.14

1.1

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

248

1500

1.68

13.12

4.5

2.8

3.54

g/l

0.01

239

1432

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

1074

1.81

13.07

5.7

5.9

856.19

1970.86

iu/ml

0.34

152

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

156

823

1.92

13.04

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

181

1002

1.83

13.03

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

106

487

2.20

12.88

1.5

1.4

2.98

2.94

g/l

0.10

354

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.70

12.80

2.4

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

286

2.57

12.67

1.2

1.1

—

1.80

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

3.40

12.57

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

105

487

2.18

12.48

1.5

1.4

0.30

0.41

g/l

3.14

352

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

277

2.58

12.44

1.5

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

105

488

2.17

12.42

1.5

1.4

6.25

6.73

g/l

0.80

353

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.02

12.40

1.3

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1572

13319

1.25

12.03

3.0

2.9

358.10

351.49

umol/l

1.39

1338

11669

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.99

11.90

1.0

1.1

—

(4062490) Immunoglobulin typing, IgG

103

484

2.15

11.87

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1580

13442

1.25

11.57

3.6

3.1

0.24

0.07

0.80

383

(3006922) Hepatitis E virus Ab [Presence] in Serum

371

2.28

11.28

1.1

—

(3010503) CD19 cells [#/volume] in Blood

292

2.45

11.18

2.3

2.5

110.35

137.25

e6/l

0.60

282

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.58

11.16

4.6

5.1

46.05

54.38

ug/min

0.21

(40768443) Skin Pathology biopsy report

325

2184

1.52

11.09

1.2

—

(21494815) CD4 cells/Lymphocytes in Specimen

406

2.21

11.07

1.8

2.5

44.77

38.56

3.29

398

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

356

2.29

11.01

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

338

2294

1.50

11.01

8.0

5.4

0.87

0.10

320

2162

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

178

1033

1.75

11.00

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.02

10.92

2.3

2.0

16.62

17.26

umol/l

0.10

(3051611) Lipemic interference index of Serum or Plasma

100

482

2.09

10.83

3.5

13.65

12.52

index

0.29

284

(3017569) Oxygen content in Arterial blood

331

2.31

10.56

1.9

2.2

16.42

16.27

0.17

331

(3039000) Anion gap in Blood by calculation

186

1109

1.70

10.45

10.5

7.3

11.93

11.34

mmol/l

1.09

168

991

(3018572) Chloride [Moles/volume] in Blood

186

1110

1.70

10.42

10.5

7.3

104.42

105.00

mmol/l

0.77

168

992

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

201

1225

1.66

10.40

1.7

2.0

4.69

8.88

iu/l

0.40

479

(3020682) Albumin/Creatinine [Ratio] in Urine

1942

17032

1.22

10.36

4.5

4.2

12.75

10.18

mg/mmol

0.92

1251

10805

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

185

2.77

10.36

1.3

3.19

4.37

umol/l

1.58

163

(3035933) Granulocytes/Leukocytes in Blood

176

1039

1.72

10.26

3.8

3.4

58.84

58.32

0.21

176

1039

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

222

1398

1.61

10.10

3.2

2.7

207.07

197.52

0.73

211

1330

(3005322) IgE [Units/volume] in Serum or Plasma

411

2952

1.42

10.00

1.4

1.3

271.95

243.04

u/ml

0.26

384

2731

(3012516) Albumin [Mass/volume] in Urine

1901

16684

1.21

9.97

3.8

3.5

66.67

50.69

mg/l

1.81

1274

10862

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

129

701

1.86

9.95

1.4

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

238

1530

1.58

9.94

2.7

91.02

91.42

0.09

228

1481

(3011985) Renin [Units/volume] in Plasma

132

725

1.84

9.85

1.5

1.4

56.03

70.74

mu/l

0.41

115

645

(3013336) Amino acids [Identifier] in Serum or Plasma

12.18

9.83

2.1

3.0

—

(3036489) Thrombin time

280

1874

1.52

9.77

2.6

2.3

21.63

21.25

0.44

252

1676

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1014

8343

1.26

9.71

1.4

1.3

32.67

33.15

iu/ml

0.03

306

2517

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

13.37

9.65

1.1

—

mmol/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

187

2.69

9.61

1.1

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

729

5763

1.31

9.57

2.2

2.4

153.61

146.37

ug/g

0.21

580

4617

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.46

9.45

1.3

1.2

0.70

0.68

umol/24h

0.05

(3000060) B lymphocytes [#/volume] in Blood

124

3.08

9.34

2.8

0.11

0.22

e9/l

1.56

(3032057) Clostridioides difficile [Presence] in Stool

109

3.23

9.28

2.0

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

262

2.38

9.27

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.05

9.23

1.9

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

117

633

1.87

9.18

1.4

—

(3000012) Reticulocyte production index

141

811

1.76

9.06

2.1

0.87

0.01

101

563

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

388

2.10

8.99

1.1

1.2

116.67

165.29

titre

—

(3049233) Organic acids panel - Urine

18.61

8.92

1.2

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

162

976

1.68

8.82

1.4

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

327

2.19

8.71

1.1

1.0

—

0.62

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.12

8.70

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4583

43938

1.25

8.67

5.8

5.3

6.07

6.01

mmol/l

2.43

4145

40150

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

523

4013

1.33

8.47

3.0

2.7

64.95

64.24

ml/min/173m2

0.09

242

1727

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

261

2.31

8.44

1.9

2.8

102.43

97.48

0.42

249

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5076

49330

1.34

8.38

46.8

27.0

39.15

40.49

12.92

5035

48712

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

216

1416

1.55

8.33

1.5

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5075

49326

1.34

8.31

45.5

26.4

91.92

91.29

16.50

5036

48727

(3010813) Leukocytes [#/volume] in Blood

5076

49339

1.34

8.29

45.8

26.5

7.23

6.82

e9/l

19.60

5000

48089

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

394

2.05

8.28

1.0

1.1

282.46

287.02

mg/l

0.19

356

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

2.65

8.27

1.3

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

125

714

1.77

8.26

1.5

1.3

0.40

0.30

nmol/l

0.17

(3007461) Platelets [#/volume] in Blood

5074

49320

1.34

8.26

45.7

26.5

247.63

246.30

e9/l

0.68

5005

48251

(3023419) Bacteria identified in Sputum by Culture

124

707

1.77

8.25

2.3

2.7

—

(3035941) MCH [Entitic mass]

5074

49327

1.34

8.19

45.4

26.4

30.42

30.38

0.81

5035

48730

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

119

672

1.79

8.18

1.3

321.03

297.20

pmol/l

0.29

566

(3026361) Erythrocytes [#/volume] in Blood

5074

49331

1.34

8.15

45.6

26.5

4.32

4.47

e12/l

70.80

4997

48089

(3009214) Lutropin [Units/volume] in Serum or Plasma

193

1240

1.58

8.14

1.8

1.4

9.95

9.26

u/l

0.27

147

988

(3000963) Hemoglobin [Mass/volume] in Blood

5074

49339

1.33

8.07

46.1

26.7

130.11

134.83

g/l

78.80

5032

48762

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

130

2.86

8.04

1.5

1.6

0.33

0.38

ug/l

0.38

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

122

698

1.76

8.03

1.5

1.3

0.65

3.19

nmol/l

0.49

117

666

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

280

2.23

8.01

3.0

2.6

43.83

38.87

1.52

151

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

387

2.03

7.93

2.5

19.63

18.99

nmol/l

0.20

364

(40768446) Kidney Pathology biopsy report

189

2.50

7.88

1.5

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

119

681

1.76

7.84

1.1

1.58

1.53

g/l

0.55

103

614

(3028679) Herpes simplex virus Ab [Presence] in Serum

226

2.36

7.83

1.2

—

(4024509) Urine culture

321

2307

1.42

7.82

2.2

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

140

840

1.68

7.79

1.4

1.5

30.75

31.57

g/l

0.31

128

752

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

185

2.50

7.71

3.6

2.7

0.60

0.61

mmol/l

0.08

185

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

525

1.86

7.67

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

197

1294

1.54

7.57

2.0

1.7

328.47

297.95

mu/l

0.54

180

1191

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.80

7.51

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

106

595

1.80

7.47

1.5

1.3

—

nmol/l

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

121

706

1.73

7.47

1.4

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

244

2.27

7.44

2.2

1.8

1.72

3.05

u/field

0.88

179

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

153

2.63

7.43

1.2

1.3

152.95

131.33

nmol/l

0.31

110

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.07

7.42

1.2

1.1

357.35

291.37

pmol/l

0.28

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

480

3713

1.32

7.35

1.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

143

878

1.65

7.31

1.5

170.86

147.70

au/ml

1.42

279

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

108

614

1.77

7.30

1.5

1.3

0.19

0.21

nmol/l

0.30

499

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

131

791

1.67

7.15

1.1

1.2

1.27

1.02

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

2.98

7.06

1.3

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

183

1206

1.54

6.96

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

408

1.92

6.88

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

408

1.92

6.88

1.2

1.3

—

titre

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.56

6.85

1.3

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

196

2.36

6.85

1.6

2.0

26.43

30.72

1.37

196

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

917

7737

1.22

6.79

1.3

11.22

12.13

u/ml

0.13

307

2937

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

503

1.82

6.78

1.2

60.20

67.76

u/l

0.35

443

(3017704) Immunofixation for Urine

282

2.10

6.69

1.8

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

154

987

1.58

6.64

2.1

2.2

3444.39

4680.90

u/l

0.25

383

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

190

1276

1.51

6.63

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

121

731

1.67

6.62

1.5

23481.61

1815.36

e6/l

1.43

514

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

435

1.87

6.62

1.4

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

195

1321

1.49

6.53

1.7

1.6

13435.59

13796.15

e6/l

0.05

147

923

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

437

1.87

6.53

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

437

1.87

6.53

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

437

1.87

6.53

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

204

1395

1.48

6.53

1.3

—

(3016750) Collection duration of Urine

272

2.11

6.50

2.4

2.1

515.16

492.50

min

0.91

199

(3028433) Virus identified in Specimen by Culture

158

2.48

6.50

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

503

1.80

6.49

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

299

2.05

6.48

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4493

43282

1.20

6.48

7.7

6.7

40.08

39.72

mmol/mol

1.77

4122

40354

(3039443) Prostate specific Ag panel - Serum or Plasma

949

0.46

6.46

1.8

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3597

37830

0.86

6.44

38.4

22.6

330.65

332.23

g/l

18.32

3575

37574

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

173

1149

1.52

6.38

1.2

1.1

4.57

4.03

0.16

118

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

209

2.26

6.38

2.3

2.8

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

115

693

1.67

6.37

2.1

2.3

32.06

32.49

0.44

115

688

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.73

6.35

2.5

2.8

0.74

0.55

u/field

0.31

(3007463) Buprenorphine [Presence] in Urine

9.25

6.28

10.5

4.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

303

2.02

6.27

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

190

1293

1.49

6.24

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

189

1285

1.49

6.24

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

353

1.94

6.18

1.1

1.4

66.00

72.50

titre

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

109

654

1.68

6.15

1.4

1.5

47274.36

66307.84

e6/l

0.44

375

(44790048) Parainfluenza type 2 nucleic acid detection

111

670

1.67

6.13

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

111

670

1.67

6.13

1.4

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

111

670

1.67

6.13

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

111

670

1.67

6.13

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

366

2798

1.33

6.12

1.3

1.2

115.16

137.50

u/ml

0.48

111

996

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

476

1.80

6.11

1.4

1.3

23.73

26.67

u/l

0.37

393

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

207

2.23

6.09

1.3

1.6

37.65

39.80

g/l

1.37

207

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1293

0.55

6.05

1.2

1.1

0.55

0.64

ratio

—

170

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.68

5.91

1.0

1.2

—

(3017509) Phencyclidine [Presence] in Urine

4.01

5.89

2.6

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

367

1.89

5.86

1.2

1.4

80.00

389.21

titre

—

(3042631) Mycobacterium sp identified in Specimen

116

720

1.62

5.77

2.4

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

516

1.74

5.72

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

154

1023

1.52

5.72

1.6

1.9

0.89

0.85

nmol/l

0.23

124

861

(21494890) Protein electrophoresis panel - 24 hour Urine

546

1.72

5.71

1.8

2.1

—

(3004775) Volume in Urine collected for unspecified duration

378

1.86

5.68

2.4

2.2

683.12

632.38

0.54

245

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

132

2.51

5.68

1.2

—

(3021788) Differential panel - Synovial fluid

145

952

1.54

5.68

1.5

—

1.00

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

214

2.16

5.64

2.3

2.4

52.29

54.35

umol/l

0.14

184

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

295

1.98

5.62

1.5

1.6

8.23

6.73

u/l

0.23

240

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.01

5.55

1.1

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

172

1182

1.47

5.43

1.6

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

139

915

1.53

5.40

1.3

296.51

270.00

u/ml

0.44

550

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

421

1.79

5.40

1.3

1.6

29.88

24.84

u/ml

0.38

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

126

812

1.56

5.38

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

173

2.26

5.38

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.18

5.31

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

175

2.24

5.24

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

296

1.94

5.23

1.2

1.4

1.87

1.20

nmol/l

2.14

212

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

340

2633

1.31

5.23

2.4

2.5

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

3.23

5.16

1.1

1.2

25.29

58.00

—

(3010838) Calcium [Moles/time] in 24 hour Urine

128

837

1.54

5.15

1.4

1.9

4.01

4.77

mmol/24h

1.88

112

729

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.01

5.09

1.3

109.93

73.25

ng/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

217

1577

1.39

5.07

1.8

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

118

761

1.56

5.05

1.2

1.1

20.94

884.82

iu/ml

0.54

153

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

110

2.55

5.03

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

177

1243

1.44

5.02

1.4

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1385

0.61

5.01

1.3

1.2

1.55

1.51

g/l

0.74

1385

(3006571) Granulocytes/Leukocytes in Synovial fluid

584

1.64

4.96

1.5

1.6

55.44

59.33

0.36

375

(3012441) Differential panel - Pleural fluid

102

640

1.60

4.91

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

110

703

1.58

4.91

1.2

3.94

4.87

u/ml

0.30

317

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

111

715

1.56

4.80

1.2

2.70

3.91

u/ml

0.54

252

(3012920) Ethanol [Mass/volume] in Serum or Plasma

11.44

4.78

1.3

1.9

1.31

2.15

g/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.21

4.76

1.4

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.79

4.70

1.4

—

(40768806) Pleura Pathology biopsy report

100

634

1.59

4.64

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

487

1.67

4.64

1.3

1.2

—

41.83

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.01

4.62

1.5

5.61

3.61

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.01

4.62

1.5

2.26

1.24

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.01

4.62

1.5

3.65

3.21

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.01

4.62

1.5

1.87

3.39

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.01

4.62

1.5

3.99

2.59

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.01

4.62

1.5

0.64

1.09

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.01

4.62

1.5

4.99

5.73

mg/l

—

(3010375) cycloSPORINE [Mass/volume] in Blood

219

2.02

4.60

33.0

28.0

106.97

118.10

ug/l

0.61

178

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

384

1.75

4.56

1.2

—

(3022145) Colonoscopy Study observation

654

5548

1.20

4.53

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

415

1.72

4.52

2.1

1.19

1.53

u/field

0.44

230

(3036180) Methadone [Presence] in Urine

10.01

4.51

1.4

2.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.82

4.49

1.5

1.88

1.87

mg/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

194

2.07

4.48

2.1

2.2

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

5.23

4.45

1.0

1.3

52.71

35.54

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

188

2.08

4.44

1.9

2.2

710.00

65469.36

u/ml

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.77

4.44

3.9

1.8

1.01

1.91

mmol/l

0.94

(3012565) Volume of 24 hour Urine

236

1.96

4.43

2.1

2.5

2390.73

1934.92

0.85

205

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

107

699

1.54

4.38

2.0

20.53

24.57

ug/l

0.66

101

687

(3020961) Endomysium IgA Ab [Titer] in Serum

270

2081

1.31

4.35

1.1

162.00

134.44

titre

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

260

1.89

4.29

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

260

1.89

4.29

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

260

1.89

4.29

2.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

260

1.89

4.29

2.0

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

551

0.43

4.29

1.4

0.82

1.14

ratio

1.39

344

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

551

0.43

4.29

1.4

1.5

1.15

0.96

ratio

0.39

344

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

551

0.43

4.29

1.4

1.5

1.21

1.18

ratio

0.08

345

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

362

1.75

4.27

1.0

312.13

308.05

ng/l

0.04

247

(3002079) Sodium [Moles/time] in 24 hour Urine

212

1.99

4.25

1.1

1.3

145.17

163.93

mmol/24h

0.80

212

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

290

1.84

4.23

1.2

29.28

23.34

u/l

0.52

240

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

545

0.44

4.18

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

193

2.03

4.17

2.1

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

193

2.03

4.17

2.1

2.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

365

1.73

4.16

1.0

34.48

41.24

ng/l

0.89

245

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.91

4.16

1.1

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

156

1113

1.41

4.13

1.1

8.51

6.96

eliau/ml

0.12

123

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

5.89

4.12

1.5

1.0

1.90

2.53

—

(37021550) Renin [Units/volume] in Plasma --upright

2.48

4.12

1.2

1.3

41.02

61.03

mu/l

0.41

(3020393) Adenovirus Ag [Presence] in Stool

2.99

4.11

1.5

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

169

1225

1.39

4.08

3.3

0.85

0.83

nmol/l

0.17

135

973

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

594

0.47

4.07

1.4

1.5

55.71

59.61

ug/l

0.15

492

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.94

4.00

1.1

—

(3022621) pH of Urine by Test strip

464

3856

1.22

3.99

2.9

2.8

6.01

6.06

0.56

301

2707

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

547

1.58

3.99

1.4

1.3

1.66

1.55

nmol/l

0.33

492

(3010144) Erythrocytes [#/volume] in Synovial fluid

494

1.61

3.94

1.5

1.3

115644.67

117770.66

e6/l

0.01

331

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

177

2.04

3.93

1.3

8.05

359.37

ug/l

1.33

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

364

1.71

3.93

1.0

590.35

718.97

ng/l

1.30

242

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

305

1.78

3.91

1.7

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.89

3.89

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.89

3.89

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

459

0.41

3.89

1.5

—

(4268621) Lupus anticoagulant assay

506

1.59

3.82

1.9

2.3

—

(4146454) Self-monitoring of blood glucose

562

1.56

3.80

2.5

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

338

1.72

3.79

1.8

1.9

8.15

8.17

mmol/l

0.01

338

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.69

3.79

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

579

1.55

3.77

1.3

1.4

906.70

329.14

u/l

0.55

550

(3005033) Fetal Nuchal fold Thickness US

452

0.42

3.76

1.4

1.32

1.28

0.15

316

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

324

1.74

3.75

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

1203

0.64

3.71

1.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

420

1.63

3.59

1.9

1.7

444.20

315.38

mu/l

0.76

334

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

314

1.73

3.57

1.4

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

130

1801

0.72

3.54

1.8

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.81

3.52

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

597

1.52

3.51

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

180

1356

1.34

3.47

4.1

3.3

1.72

1.64

mmol/l

0.42

172

1314

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

243

1.82

3.47

1.3

72.40

66.97

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.89

3.46

2.7

1.3

—

12.88

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

665

1.48

3.44

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

471

0.46

3.35

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

154

2.02

3.34

1.5

66.00

307.51

nmol/24h

0.72

154

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

325

3945

0.81

3.27

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.30

3.26

1.3

1.4

—

(3049717) Cytology report of Urine Cyto stain

262

2095

1.26

3.25

2.1

2.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

251

1998

1.27

3.24

1.3

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

5.34

3.19

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

157

1.98

3.18

1.2

11.60

23.94

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

357

1.63

3.15

1.4

1.5

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.36

3.14

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

111

2.17

3.12

1.1

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

105

2.20

3.08

1.3

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

314

1.66

3.05

2.2

1.8

106.10

118.77

ng/l

0.42

314

(40762814) Titanium [Mass/volume] in Blood

2.38

3.05

2.3

2.4

4.30

4.02

ug/l

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

7.51

3.05

1.0

1.50

1.00

u/field

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

450

1.54

2.97

1.4

1.5

16.42

28.59

3.10

279

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.44

2.89

1.2

2.10

1.51

iu/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

378

3185

1.20

2.89

1.7

1.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

251

1.72

2.87

1.2

1.1

1.08

1.06

ratio

0.59

198

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

543

1.48

2.87

1.7

1.4

0.22

0.33

nmol/l

2.89

408

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.67

2.86

2.0

1.9

422.33

321.44

ug/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

143

1.96

2.84

1.1

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

687

1.42

2.79

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

664

1.42

2.75

1.1

121.56

114.28

1.07

599

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

216

1734

1.26

2.66

1.6

18.63

17.50

u/ml

0.07

367

(3033086) Enterovirus Ab [Titer] in Serum

4.67

2.59

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

395

3381

1.18

2.56

2.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

701

0.62

2.54

3.5

4.0

108.34

31.80

u/ml

0.52

680

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.60

2.53

1.2

1.89

1.72

umol/24h

0.31

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.60

2.53

1.2

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

470

1.47

2.48

2.1

2.4

25.19

33.30

iu/ml

0.25

(4015189) Microbial culture of sputum

123

1.96

2.44

2.9

2.2

—

(3006270) Folate [Moles/volume] in Blood

415

1.50

2.43

1.3

1.2

366.78

355.57

nmol/l

0.17

353

(3001556) Androgen free Index in Serum or Plasma

3.34

2.39

1.8

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

153

1.83

2.37

1.2

13.30

10.55

pmol/l

—

(3016244) Insulin [Units/volume] in Serum or Plasma

251

1.64

2.36

1.9

3.2

27.56

23.38

mu/l

0.22

238

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.12

2.36

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

260

1.62

2.32

1.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

126

1.91

2.30

6.2

7.1

52.82

72.51

1.08

101

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.38

2.29

1.3

2.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

141

1.85

2.27

2.2

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.48

2.27

4.1

5.8

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.48

2.27

1.3

1.6

20.15

34.41

nmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

207

1688

1.24

2.26

1.7

1.4

24.74

27.31

iu/l

0.55

161

1418

(3034891) Synovial lining cells/cells in Synovial fluid

231

1.65

2.26

1.4

1.5

0.67

3.76

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

240

1.63

2.21

1.2

490.76

331.26

u/l

0.26

224

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

642

1.38

2.21

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

422

3685

1.16

2.17

2.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1015

0.72

2.16

1.3

1.6

1298.16

980.50

mu/l

1.02

834

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

151

1.79

2.15

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.29

2.15

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.29

2.15

1.2

1.0

—

(4195642) Thrombophilia screening test

654

1.37

2.15

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

142

1120

1.27

2.09

1.3

257.31

211.93

miu/ml

0.48

470

(3036670) Protein [Mass/volume] in Synovial fluid

160

1.75

2.09

1.4

1.2

43.68

39.93

g/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

245

1.60

2.06

1.6

1.7

3.35

6.96

nmol/l

0.75

203

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

147

1167

1.27

2.06

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

149

1185

1.26

2.06

2.6

2.3

177.25

108.37

ug/min

0.93

719

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

176

1.71

2.05

3.3

2.5

5.03

4.85

kpa

0.48

176

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

176

1.71

2.05

3.3

2.5

11.01

9.99

kpa

1.03

176

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

583

1.38

2.05

3.1

3.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

132

1.82

2.03

1.2

1.3

105.42

102.86

0.12

121

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.23

2.00

1.0

1.2

20.93

23.01

u/l

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1852

19469

0.93

1.95

2.0

1.9

1.49

1.36

mmol/l

5.50

1555

16350

(40768804) Tissue Pathology biopsy report

1986

18924

1.08

1.92

2.3

2.2

—

(3014891) Appearance of Pleural fluid

2.00

1.90

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

675

0.68

1.88

1.5

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.86

1.86

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.86

1.86

1.0

1.9

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.86

1.86

1.4

1.0

—

(4211845) Urine protein measurement

229

1.58

1.84

4.7

3.5

—

(3042733) HLA Ab [Presence] in Serum

160

1.69

1.81

5.1

4.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

130

1.77

1.81

1.1

1.2

92.00

89.21

0.13

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

511

1.37

1.81

1.1

1.2

95.97

96.48

0.05

482

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1008

10831

0.92

1.80

3.0

3.3

0.72

0.79

ug/l

1.52

700

7219

(40762887) Creatinine [Moles/volume] in Blood

2.76

1.79

1.5

1.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.34

1.74

1.3

1.1

161.50

283.00

nmol/l

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.34

1.74

1.2

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.67

1.72

1.0

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.67

1.72

1.1

—

38.80

—

(3002619) Bacteria identified in Specimen by Culture

118

1.78

1.69

1.4

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

291

1.48

1.69

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

291

1.48

1.69

1.3

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

126

1.75

1.67

1.3

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

710

1.30

1.67

1.1

22.15

18.94

au/ml

0.12

152

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

104

1.83

1.67

2.9

1.7

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

260

1.50

1.65

1.5

2.7

211.54

205.62

u/l

0.20

255

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

236

1.53

1.64

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

351

1.43

1.64

1.1

1.2

88.80

79.82

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

427

1.39

1.63

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

181

1.61

1.63

1.2

1.5

—

(3044889) 12 lead EKG panel

3403

33160

1.07

1.62

5.0

4.3

0.67

5150.81

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

190

1597

1.20

1.62

1.9

2.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.95

1.59

3.7

6.5

—

776.00

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.69

1.58

3.6

3.7

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

184

1.58

1.54

1.3

1.5

3.71

2.50

0.27

155

(3006462) Nitrate [Presence] in Urine

208

1.54

1.53

5.1

3.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

150

1241

1.21

1.53

5.5

4.4

—

(3035880) pH of Pleural fluid

323

1.43

1.52

1.3

7.36

7.41

0.68

227

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

130

1.70

1.52

1.1

1.4

90.54

88.01

0.11

(3001964) Herpes simplex virus Ag [Presence] in Specimen

130

1.70

1.52

1.3

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.86

1.50

1.2

1.0

—

0.15

—

(3032773) Endomysium IgG Ab [Titer] in Serum

426

1.37

1.49

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

785

1.27

1.49

1.5

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

503

5534

0.90

1.49

1.6

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

109

1.75

1.46

1.1

—

(3034426) Prothrombin time (PT)

148

1.62

1.43

1.1

1.3

28.79

28.80

0.00

148

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

156

1.61

1.43

1.0

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

125

1.68

1.43

2.0

1.4

—

0.25

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.42

1.39

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.42

1.39

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.42

1.39

1.0

2.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

158

1.58

1.37

1.2

1.3

0.31

0.30

g/l

0.15

126

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.20

1.36

6.3

3.9

—

(3050794) Legionella sp Ab [Presence] in Serum

2.20

1.36

1.0

—

(3000330) Specific gravity of Urine by Test strip

292

2582

1.14

1.35

4.3

3.5

1.02

ratio

0.06

265

2360

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1898

18237

1.06

1.35

4.9

5.6

3.18

3.28

ug/l

0.08

1677

16489

(3024263) Appearance of Synovial fluid

273

1.43

1.34

1.4

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.04

1.32

2.3

2.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

121

998

1.22

1.31

1.2

1.3

22.21

42.07

u/l

3.13

862

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

612

1.28

1.31

1.1

3.80

3.37

—

(3004451) EKG impression Narrative

335

1.38

1.28

1.3

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.94

1.27

1.3

1.2

10.10

5.70

mmol/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

115

1.65

1.24

2.3

2.4

936.89

312.66

ug/l

0.28

115

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

593

5481

1.09

1.24

3.2

4.2

58.05

23.68

ug/l

0.35

471

4517

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

277

0.61

1.22

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

221

1.45

1.20

1.3

1.5

62.44

65.38

0.18

179

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

340

1.36

1.19

2.4

1.9

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.11

1.18

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

125

1.60

1.17

5.1

7.4

6.35

5.35

kpa

0.64

125

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

1.16

0.0

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

342

1.35

1.15

1.3

3.31

2.54

u/ml

0.10

203

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.15

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

104

1.64

1.09

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

144

1.53

1.08

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.65

1.06

5.1

7.6

10.66

10.32

0.17

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

1.65

1.06

1.2

1.5

9.00

6.62

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

137

1.53

1.05

1.0

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

162

1.48

1.04

1.4

1.3

72.56

58.70

1.33

135

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.27

1.03

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

482

1.27

1.02

1.6

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

106

1.61

1.02

1.4

1.9

—

(44806071) Cardiolipin IgM antibody measurement

1.89

1.01

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.00

1.00

5.7

6.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.84

0.98

1.2

1.1

0.11

0.03

u/ml

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.95

0.97

1.4

1.2

6.30

6.10

mmol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

704

1.21

0.95

1.2

—

(3025577) Chromium [Mass/volume] in Blood

302

1.33

0.95

2.0

2.3

1.89

2.00

ug/l

0.14

254

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

706

1.21

0.93

2.7

4.35

662.68

u/ml

0.96

695

(3046861) Legionella sp Ag [Presence] in Urine

2.22

0.93

1.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

619

1.21

0.89

1.3

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.86

0.87

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

215

1932

1.12

0.85

2.0

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

221

1.36

0.85

1.1

—

(3008898) HLA-B27 [Presence]

160

1416

1.13

0.82

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

121

1.49

0.82

1.2

1.94

1.61

mmol/l

0.47

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.55

0.81

1.7

1.3

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

130

1.46

0.80

1.1

1.3

26.00

33.83

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.78

0.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1417

14649

0.96

0.77

4.0

4.6

21.94

22.03

0.07

697

7311

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

125

0.56

0.77

1.1

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

314

1.28

0.76

2.0

1.5

69.50

85.91

umol/l

3.25

314

(3017446) Testosterone [Moles/volume] in Serum or Plasma

490

4604

1.07

0.75

2.8

2.3

11.99

13.28

nmol/l

2.96

432

4142

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

3.63

0.21

u/ml

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

202

1.34

0.72

2.6

2.1

743.17

4481.84

e6/l

0.50

146

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

185

1.35

0.71

1.0

1.1

98.05

94.08

0.14

142

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.58

0.71

1.8

1.6

45.89

45.54

umol/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.92

0.70

1.4

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

102

1.47

0.67

1.0

1.2

1.19

146.08

mg/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

318

0.75

0.67

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.79

0.66

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

595

1.18

0.66

3.1

3.5

80.43

15.11

nmol/l

0.40

581

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

277

1.27

0.65

3.2

4.1

—

(3044007) Cell count panel - Peritoneal fluid

181

1.33

0.63

2.8

1.9

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

104

0.58

0.61

6.3

6.0

7.50

8.08

—

104

(40761995) Spermatozoa Progressive [#/volume] in Semen

104

0.58

0.61

3.2

3.0

43.00

42.77

—

104

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.61

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

637

1.16

0.61

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.46

0.61

2.0

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

717

0.85

0.61

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

227

1.28

0.59

1.2

1.3

6.04

5.93

mmol/l

0.15

215

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.54

0.59

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

345

1.22

0.58

1.8

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

175

1.32

0.58

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.72

0.57

1.3

1.2

—

(4133840) Spirometry

116

0.60

0.57

1.4

1.2

—

(1002224) Polysomnography panel

187

2035

0.92

0.56

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

985

0.88

0.54

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

142

1.34

0.54

1.4

1.5

10.09

8.86

ug/l

0.55

142

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

141

1280

1.10

0.54

2.0

1.9

212.88

207.36

pmol/l

0.16

131

1218

(3002523) Influenza virus A Ag [Presence] in Specimen

718

0.86

0.53

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.54

0.53

4.3

2.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.45

0.53

1.0

1.1

77.87

71.56

ug/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.50

0.51

1.7

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

100

0.60

0.51

2.7

1.7

—

62.96

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

234

1.24

0.49

3.7

3.3

1.69

1.37

0.33

234

(3020650) Glucose [Presence] in Urine

154

1.30

0.48

1.7

1.8

0.00

0.04

estimate

0.80

154

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

234

0.77

0.48

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

119

1.35

0.48

1.3

1.17

mmol/l

0.06

119

(4094501) Cardiovascular stress test using bicycle ergometer

124

1361

0.91

0.47

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

102

1.37

0.47

1.2

1.27

2.45

mmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

108

1192

0.90

0.46

1.2

1.4

—

(4034850) Laboratory test

135

1468

0.92

0.43

15.0

11.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.52

0.41

1.2

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

175

1632

1.07

0.40

1.9

38.93

41.13

nmol/l

0.55

167

1583

(40763590) HLA-DQ beta [Type]

0.00

0.40

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.40

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.40

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.40

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.40

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.1

—

14.60

—

(44813793) Dust mix specific IgE antibody measurement

278

1.19

0.39

1.1

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4413

44392

0.97

0.39

5.4

5.1

1.41

1.43

mmol/l

3.79

4002

41029

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

367

0.84

0.38

1.7

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

133

1.28

0.38

2.2

1.3

25.38

25.31

g/l

0.01

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.39

0.38

1.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

124

1146

1.08

0.37

2.5

3.5

289.72

747.17

u/ml

0.91

112

1048

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.39

0.36

19.2

12.3

3.70

5.75

mmol/l

—

(3045142) Bone marrow Pathology biopsy report

629

0.89

0.36

1.1

1.3

—

(3020491) Glucose [Moles/volume] in Blood

353

0.85

0.36

1.5

2.2

6.23

6.78

mmol/l

1.31

243

(44806420) Estimation of glomerular filtration rate

470

0.87

0.35

2.3

2.4

—

(3025130) Human papilloma virus identified in Specimen

517

1.12

0.35

1.7

1.8

—

(3024471) HLA-A [Type]

153

1.24

0.35

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.36

0.34

5.3

2.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

471

1.13

0.34

1.4

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.70

0.33

2.7

1.5

0.58

0.49

e9/l

—

(3051101) Glucose [Moles/volume] in Cord blood

0.67

0.32

5.7

6.9

7.68

8.39

mmol/l

—

(40765096) Chromosome analysis panel by Banding

164

1.22

0.32

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.28

0.32

1.0

1.1

160.00

87.15

titre

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.35

0.32

1.0

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

391

1.13

0.29

4.0

5.4

54.17

63.28

u/ml

0.10

120

(40768441) Liver Pathology biopsy report

363

1.13

0.29

1.7

1.4

—

(3024932) HLA-DR beta [Type]

149

1.21

0.27

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

113

1.24

0.26

1.3

1.2

136.56

138.94

mmol/l

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.23

0.25

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.23

0.25

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.23

0.25

1.3

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

516

0.91

0.23

1.1

0.48

0.26

u/ml

0.31

194

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

727

7123

1.02

0.23

1.6

1.5

—

(3019174) dRVVT (LA screen)

1.32

0.23

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

264

0.87

0.23

6.2

6.8

7.73

140.31

ug/l

0.94

170

(3003694) ABO and Rh group [Type] in Blood

1330

13120

1.02

0.22

1.3

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

—

10.81

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

172

1.16

0.22

2.8

1.9

827.78

17799.24

e6/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.22

0.22

1.0

—

0.60

—

(3013727) Leukocytes other/Leukocytes in Blood

163

1.17

0.21

4.9

3.6

58.89

53.89

0.50

156

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

203

2110

0.96

0.21

2.8

3.7

52.77

77.39

u/ml

0.81

198

2036

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

188

0.85

0.21

1.2

12.88

10.60

mm/h

0.41

188

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

5.58

—

(3001729) Color of Synovial fluid

1.25

0.20

1.3

1.4

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.18

0.19

37.0

10.0

0.28

0.20

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

549

1.08

0.19

1.1

2.44

4.30

u/ml

0.90

257

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

362

0.91

0.17

1.4

1.5

58.17

57.91

ug/l

0.01

362

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4457

44704

0.98

0.17

5.4

5.2

4.46

4.54

mmol/l

5.22

4059

41604

(3005011) Chlamydia sp Ab [Titer] in Serum

1.14

0.16

1.4

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.13

0.16

1.0

1.2

64.75

65.80

ug/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

111

1.17

0.15

1.5

2.3

6.14

7.86

mmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

747

0.95

0.14

1.1

4.37

4.56

u/ml

0.04

409

(3002256) Pathology report gross observation

647

6562

0.98

0.14

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

248

1.09

0.12

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

293

0.92

0.12

1.1

17.58

18.43

u/ml

—

111

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3777

37653

1.01

0.12

36.0

21.7

14.05

13.72

34.20

3751

37140

(3014599) Egg white IgE Ab [Units/volume] in Serum

220

0.91

0.12

1.0

1.1

8.88

2.43

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

162

1.11

0.11

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

320

3143

1.02

0.11

1.2

1.3

—

(40768793) Breast Pathology biopsy report

100

1035

0.97

0.11

1.5

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4253

42433

1.01

0.11

4.6

4.4

1.40

1.30

mmol/l

14.32

3820

38808

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.15

0.10

1.1

1.0

17.75

38.32

iu/ml

1.46

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

193

1.09

0.10

1.2

1.3

—

(21494434) Karyotype in Bone marrow

493

0.95

0.09

1.1

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.09

0.08

1.8

1.3

—

640.53

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.07

0.08

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

349

0.95

0.08

1.2

1.4

124.74

192.60

pmol/l

1.44

349

(3025018) Bordetella pertussis Ab [Titer] in Serum

302

1.06

0.08

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.04

0.08

2.1

6.3

16.29

770.90

mg/mmol

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

190

1934

0.98

0.07

2.7

3.5

138.88

2902.70

u/ml

1.22

160

1663

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

133

0.90

0.07

3.0

3.3

—

109.43

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

530

1.04

0.07

1.2

1.3

7.96

7.34

mmol/l

0.78

461

(3035320) C reactive protein [Mass/volume] in Body fluid

383

1.04

0.07

2.2

2.7

34.46

31.52

mg/l

0.17

278

(3008401) Mugwort IgE Ab [Units/volume] in Serum

730

0.97

0.06

1.1

1.33

1.21

u/ml

0.06

339

(4281824) Cell count and differential, peritoneal fluid

487

0.96

0.06

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

227

2241

1.01

0.06

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

129

1.09

0.05

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

159

1.07

0.05

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

110

0.91

0.05

1.0

1.1

3.87

8.96

u/ml

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

258

1.05

0.04

2.1

144.00

217.18

ug/min

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

484

0.97

0.04

1.4

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

397

1.03

0.04

1.8

2.2

16.57

9.73

umol/l

0.36

283

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

866

0.98

0.04

1.2

1.1

2.44

2.05

u/ml

0.10

485

(3020874) Milk IgE Ab [Units/volume] in Serum

230

0.96

0.03

1.0

1.1

19.77

2.71

u/ml

0.40

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

140

1416

0.99

0.03

1.7

7.21

4.70

mg/l

0.87

109

1058

(3026692) Albumin [Mass/volume] in Peritoneal fluid

159

0.94

0.03

1.2

1.4

10.86

12.90

g/l

—

116

(3051387) C reactive protein [Mass/volume] in Capillary blood

104

1049

0.99

0.01

3.8

3.6

29.37

28.36

mg/l

0.11

731

(3014133) Dog dander IgE Ab [Units/volume] in Serum

588

0.99

0.01

1.1

7.49

2.68

u/ml

0.70

306

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

377

0.98

0.01

1.0

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

687

0.99

0.01

1.1

2.57

1.41

u/ml

0.40

372

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

324

1.02

0.00

1.0

1.1

8.20

9.05

iu/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

434

1.01

0.00

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

454

1.01

0.00

2.5

3.0

41.03

54.12

mg/l

0.24

348

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4547

45464

1.00

0.00

6.1

6.0

2.56

2.64

mmol/l

6.15

4133

42149

(3015076) Soybean IgE Ab [Units/volume] in Serum

195

1.03

0.00

1.1

1.04

1.96

u/ml

—

(40768795) Lymph node Pathology biopsy report

482

1.00

0.00

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

555

1.01

0.00

1.1

5.62

2.78

eliau/ml

0.28

225

(3042111) Morphology [Interpretation] in Bone marrow Narrative

955

1.01

0.00

1.4

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.03

0.00

1.5

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

226

1.02

0.00

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

167

1.02

0.00

1.7

1.6

8.55

8.28

mmol/l

0.14

162

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

147

1471

1.00

0.00

1.8

—

32.21

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.0

—

0.24

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

1.00

—

(4212803) Bone marrow aspirate examination

0.91

0.00

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.97

0.00

1.3

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

3083.33

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.99

-0.00

1.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

11.28

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.94

-0.00

1.1

1.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.00

-0.00

1.2

1.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

1.67

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.98

-0.00

1.2

3.97

8.25

mg/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MYONEU and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_MYONEU	2.179 [1.94, 2.45]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.026

During the follow-up period (1.1.1998 — 31.12.2019), 5630 out of 15018 females with G6_MYONEU died.

Males

Parameter	HR [95% CI]	p-value
G6_MYONEU	2.996 [2.64, 3.4]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 7312 out of 17909 males with G6_MYONEU died.

Mortality risk

Mortality risk for people of age

years, who have G6_MYONEU.

N-year risk	Females	Males
1	0.158%	0.431%
5	1.15%	3.041%
10	2.834%	7.753%
15	5.241%	15.018%
20	9.066%	25.303%

Relationships between endpoints

↥

Index endpoint: G6_MYONEU – Diseases of the myoneural junction and muscle

GWS hits: 18

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diseases of the myoneural junction and muscle

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints